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ABSTRACT 
Introduction:  
The link between Streptococcus mutans and dental caries is well documented. The use of natural 
plant products in the treatment of oral diseases is gaining popularity. One plant that has gained 
recognition as a source of traditional medicine is Dodonaea viscosa var. angustifolia. The aim of 
this study was to analyse the phytochemical constituents of D. viscosa var. angustifolia (DVA) 
and establish their beneficial effects against S. mutans. 
Materials and methods 
Cultures of S. mutans ATCC 10923 and SM1 were obtained from the Oral Microbiology 
laboratory and the DVA was collected from the Pypeklipberg, Mkhunyane Eco Reserve, South 
Africa. Dry DVA leaves were extracted with methanol. The crude extract was fractionated into 
six fractions (F1-F6) using silica gel column chromatography and thin layer chromatography.  
The Minimum Inhibitory Concentrations (MIC) and Minimum Bactericidal Concentration 
(MBC) of the crude extract and six fractions were determined using microtitre plate dilution 
technique. The effect of the crude extract and fractions on biofilm formation and acid production 
were investigated using standard techniques. The bioautography technique was also used to 
identify fractions with bioactive compounds. The most active fraction (F5) was further 
fractionated and purified into two subfractions, 5.1 and 5.2. Both subfractions were further 
screened to identify the most beneficial subfraction (5.1). Subfraction 5.1 was identified and 
elucidated using GC-MS and NMR. The effect of the purified compound on biofilm formation 
and acid production on S. mutans was repeated to establish reproducibility of the results. 
Cytotoxic effect of the crude extract and identified subfraction (5.1) was studied using human 
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embryonic kidney cells (HEK). The results were analyzed using Wilcoxon rank-sum test (Mann-
Whitney). 
Results  
The MIC and MBC of the six fractions and crude extract ranged from 0.39 to 12.5 mg/ml.  On 
preliminary screening of 6 fractions, F5 showed lowest MBC of 0.39 mg/ml and highest total 
activity value of 2000. In addition, at 0.2 mg/ml, F5 reduced biofilm formation by 93.3% and 
reduced acid production in S. mutans. Purification of F5 produced subfraction 5.1 and 5.2. 
Subfraction 5.1 showed higher antimicrobial activity (MIC-0.05 mg/ml) compared to the crude 
extract (MIC-0.78 mg/ml) and subfraction 5.2 (MIC-0.78 mg/ml). At a concentration of 0.05 
mg/ml, subfraction 5.1 exhibited an inhibitory effect on biofilm formation at both 6 hours (94% 
reduction) and 24 hours (99% reduction) which was higher compared to the crude extract (87% 
reduction at 0.78 mg/ml after 6 hours). Subfraction 5.1 also exhibited a higher inhibitory effect 
on acid production compared to the crude extract. Subfraction 5.1 was identified as, 5,6,8-
Trihydroxy-7,4
l
-dimethoxyflavone. Cytotoxicity analysis of the crude extract and subfraction 5.1 
(5,6,8-Trihydroxy-7,4
l
-dimethoxyflavone) on HEK 293 cells showed IC50 values of 0.09 mg/ml 
and 0.03 mg/ml respectively. 
Conclusion 
Phytochemical analysis of D. viscosa var. angustifolia produced an anticariogenic constituent, 
5,6,8-Trihydroxy-7,4
l
-dimethoxyflavone. The compound showed improved antimicrobial and 
anticariogenic activity at lower concentrations than the crude extract. At subinhibitory 
concentrations, the compound significantly inhibited biofilm formation and acid production by S. 
mutans. Cytotoxicity analysis established the safe use of this newly isolated compound therefore 
it has potential to be used in the oral cavity to prevent dental caries. 
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                                              CHAPTER 1 
                                              Introduction  
The impact of oral diseases on mankind continues to be a major health problem. Dental 
caries and periodontitis are the most prevalent oral ailments. Regardless of advanced 
developments in the health care system of people living in developed nations, as high as 90% 
of school aged children have dental caries and a high percentage of adults are also affected        
(Petersen, 2003). Up to 10% of public health care expenditure in industrialized countries is 
also related to curative dental care; hence its economic impact factor can hardly be ignored 
(Rautemaa et al., 2007).  
 
The link between oral microorganisms and oral diseases is well documented. The onset of 
dental caries primarily involves aciduric and acidogenic Gram-positive bacteria collectively 
called mutans streptococci. These facultative anaerobes metabolize dietary sucrose and 
produce organic acids, mostly lactic acid, which dissolves the teeth enamel leading to 
eventual teeth decay (Palombo, 2009).  
 
The use of natural plant products in the treatment of oral diseases is gaining popularity. 
Henley-Smith et al (2013) reports that, in Burkina Faso alone, over 62 plant species which 
belong to 29 families have been documented to treat oral diseases, which include dental 
caries. One plant that has been identified as a potential source of traditional medicine in the 
prevention of dental caries is Dodonaea viscosa var. angustifolia (DVA).  
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Various studies have been done on the potential use of D. viscosa var. angustifolia leaves as 
an anticariogenic agent. It is important to note though that most of these D. viscosa var. 
angustifolia studies have focused mainly on the use of crude extracts.  Other studies have 
established the safe use of D. viscosa var. angustifolia leaves. The aim of this study therefore 
was to go beyond the screening of D. viscosa var. angustifolia as an antimicrobial agent by 
identifying chemical constituent responsible for its anticariogenic properties against the 
dental caries causing bacteria, S. mutans. Optimized solvent systems were used for extracting 
constituent phytochemicals followed by bioassays to evaluate the bioactivities of the 
fractions against S. mutans and its virulence factors.  
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1.  Literature Review  
1.1 Pharmacognosy 
Pharmacognosy is the study of medicines from natural products and their use in the 
improvement of health. Pharmacognosy used to be focused mainly on the morphological 
description of plants, but it has now extended to include the molecular science aspect of their 
active ingredients, mode of action and application. Improvements in isolation and structure 
determination techniques over the years has facilitated the shift from focusing on plant 
species used in traditional medicine only, to include exploitation of the huge molecular 
diversity found in plants, microorganisms and animals (Kato and Pezzuto, 2011).  
 
The demand for phytomedicine is increasing which is supported by the huge investments that 
are being made by the private sector. Plant-based drugs which include, Camptothecin, 
Vinblastine, Vincristine, and Paclitaxel exceeded 65 billion dollars in sales in 2003 
(Gordazila, 2009). For an industry that is producing billions of dollars per annum, it is 
interesting to note that as recent as 2008, Africa contributed only 1 % in sales despite the fact 
that 75 % of the population is still dependent on traditional herbal medicine (Henley-Smith, 
2013). 
 
There are three major disciplines in the search for new bioactive molecules from plants. The 
first discipline is evidence based phytotherapy approach. This technique is simpler in the 
sense that the search for new lead compounds is guided by the way the plants are used in 
traditional medicine (Kato and Pezzuto, 2011). According to Fabricant and Fansworth 
(2001), 88 chemical constituents in modern therapy that have been isolated from 72 
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medicinal plants possess the same or similar beneficial purpose as their original ethno-
medicinal use. The second discipline is chemotaxonomy in which plants that fall in the same 
taxonomic group as those that have exhibited the presence of specific active compounds are 
targeted. Finally, the third discipline is high throughput-screening. This is a random and 
systematic evaluation of vast libraries of chemicals likely to control a specific biological 
target (Kato and Pezzuto, 2011). The method has several advantages in that it is fast and a 
vast number of assays can be done in a single day (Bruno et al, 2014).  
 
1.1.1 Plant chemistry (phytochemistry) 
Phytochemistry refers to the chemistry of natural products. In essence, phytochemistry 
covers the wide range of different types of organic substances that are produced by plants 
(Kar, 2007). Prior to the 1800’s, relatively small progress had been made in the field of 
phytochemistry due to the lack of techniques to isolate and elucidate different organic 
compounds from plants. Compounds like starch, camphor and benzoic acid had been isolated 
as the techniques involved were simple. Narcotine, the first alkaloid was isolated followed by 
morphine, strychnine and emetine (Evans, 2002). Currently, with the dawn of advanced 
analytical procedures, the detailed phytochemical study of an unknown plant can be carried 
out from elucidation of the structure of the isolated constituents to the detailed study of their 
biological characteristics (Kar, 2007).   
 
The vast numbers of chemical compounds that exist in the plant-kingdom in one form or the 
other are called ‘constituents’. There are two main categories of constituents, namely, active 
constituents and inert constituents. Active constituents are chemical compounds that are 
responsible for the actual therapeutic activities which include pharmacological and anti-
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microbial characteristics. Preliminary screening of plant crude extracts is usually done to 
determine the presence of these active constituents. Active constituents include glycosides 
alkaloids, steroids and terpenoids. Inert constituents are chemical compounds that exist in 
plant and animal kingdoms but they not do have any definite therapeutic uses. They can 
however, serve as adjuncts in drug development or in surgery. Examples are cellulose, starch, 
albumin, keratin and some chemicals used in food coloring (Kar, 2007). This group of 
constituents is also known as essential nutrients (Pengelly, 1996). Figure 1.1 gives a general 
outline of the stages involved in extracting, isolating and elucidating chemical constituents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: General approaches in extraction, isolation and elucidation of chemical  
                    constituents (Sasidharan et al., 2011). 
                   Purification 
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1.1.2 Drug Biosynthesis (Biogenesis) 
Drug biosynthesis is the study of biochemical pathways that lead to the formation of active 
constituents or secondary constituents. With the dawn of the use of isotopes in labeling 
organic compounds in the fifties, it became possible to prove scientifically that amino acids 
together with their corresponding derivatives more or less acted as precursors of complex 
alkaloids. This had been hypothesized by Trier in 1912 (Kar, 2007). The structure of the 
plant cells plays an important role in biochemical reactions. The various organelles in the cell 
and their arrangement promote variability in chemical environments within the cell and 
increases the surface area needed for biochemical reactions (Evans, 2002).  
 
Pharmacologically active chemical constituents from plants are essentially comprised of 
large and complex molecules that have one or more chemical functional groups that are 
responsible for characteristic features of phenols, alcohols aldehydes, esters, oxides, ketones 
and organic acids (Kar, 2007). The synthesis of these molecules with functional groups is 
mostly enzyme dependent. These enzymes act as organic catalysts and recently, organic 
chemists are exploiting their potential ability to catalyze single-step transformations. They 
have observed that these enzymes can achieve accurate stereo-chemical characteristics which 
are important for drug synthesis (Evans, 2002). Figure 1.2 gives a summary of the 
biosynthetic pathways and inter-relationships that lead to the formation of various secondary 
constituents.  
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Figure 1.2: Biosynthetic pathways and their interrelationships (El-Hadary and Chung, 2013). 
 
1.2 Phytotherapy in dentistry 
In recent years there has been a rise in the global search for alternative medicine in the 
treatment of oral diseases like dental caries, periodontal diseases, soft tissue conditions and 
oral candidiasis. The main reason that has been documented is the increase in pathogenic 
resistance to currently existing antibiotics and chemotherapeutics. There are several synthetic 
medicines that have been introduced in the market to treat oral diseases, examples being 
cetylpyridinium chloride, amine fluorides and other products containing these agents (Knoll-
Kohler and Stiebel, 2002). However, the use of these products has been shown to have toxic 
adverse effects which include teeth staining. Ethanol which is found on some of the existing 
mouth rinses in the market has been linked to oral cancer (Rodrigues et al, 2007).  The 
objective of these drug discovery programs in phytotherapy therefore is to produce safe 
herbal products that are effective and also economically viable for use in developing 
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countries (Palombo, 2009). Improving drug delivery systems has also been an area of focus. 
Nanotechnology and phototherapy have shown considerable potential in enhancing drug 
delivery in the prevention of dental biofilms. When drugs are used in combination with 
nanoparticles (NPs) which are minute in size, it increases their solubility and ability to adhere 
to biological surfaces thereby improving bioavailability and therapeutic activity 
(Bamrungsap et al, 2012). Phototherapy is also based on the use of light sensitive 
nanoparticles that can be activated at the targeted site using laser light. This enhances the 
efficacy of the drug (Adnan et al, 2016).  
 
Herbal products are used in dentistry as anti-inflammatory agents, antibiotics, analgesics, 
sedative agents and also as endodontic irrigants (Calixto, 2000). There is a wide variety of 
plant products that are added to dentifrice and mouth rinsing solutions to prevent oral 
conditions like caries or biofilm formation (Pannuti et al, 2003).  Parodontax® 
(GlaxoSmithKline, Middlesex, UK) a herbal medicine widely used in dentistry contains 
various herbal products that include: Matricaria chamomilla (Asteraceae) which possesses 
anti-inflammatory properties that reduce gingival inflammation; Echinacea purpurea 
(Asteraceae) which stimulates the immune response; Salvia officinalis (Lamiaceae) which 
has anti-hemorrhagic properties; Commiphora myrrha (Burseraceae) has natural antiseptic 
properties and Mentha piperita (Lamiaceae) has analgesic, antiseptic and anti-inflammatory 
properties (Groppo et al, 2008). 
 
A noteworthy reduction in gingival index was reported by Pistorius et al (2003) from the use 
of a herbal-based mouth rinse which contained M. piperita (menthol), S. officinalis, M. 
chamomilla, C. myrrha, Eugenia caryophyllus (Myrtaceae), Carum carvi (Umbelliferae) and 
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E. purpurea. From this study they concluded that the daily use of this mouth rinse as an 
adjunctive could reduce gingival inflammation in patients with periodontal ailments 
(Pistorius et al, 2003).  Aloe vera has been shown to treat aphthous ulcers and is also able to 
reduce chances of developing alveolar osteitis after third molar extraction surgeries (Wynn, 
2005). Scherer et al (1998) established that a mouth rinse containing Aloe vera was able to 
reduce gingival bleeding and gingival inflammation significantly. Kaim et al (1998) further 
proved that the mouth rinse was more effective than Listerine® in reducing anaerobic, 
aerobic and microaerophilic bacterial counts.  
 
In an investigative study done by Almas (2002) to compare the effect of 0.2% chlorhexidine 
and 50% Salvadora persia on human dentine surfaces, he concluded that Salvadora Persia 
was more efficient in removing biofilms from teeth than chlorhexidine. In another 
comparative clinical study, Allium sativum (tea tree) was shown to be more effective as an 
antimicrobial agent followed by garlic and chlorhexidine which had the same results (Groppo 
et al., 2002). Tea tree oil also displayed antimicrobial activity against a range of oral 
microorganisms including Candida albicans (Wilkinson and Cavanagh, 2005). Dodonaea 
viscosa var. angustifolia is another plant that is gaining recognition as a potential source of 
antimicrobial agents in oral hygiene.  
 
1.3 Dodonaea viscosa var. angustifolia (DVA) 
Dodonaea viscosa falls under division Angiosperm, subclass Dicotyledonae and Sapindaceae 
family of plants. The genus Dodonaea was named after a Dutch botanist, Rembert Dodoens. 
The term viscosa means sticky and refers to the young growing tips which contain flavonoids 
on their surface giving them a shiny appearance. 
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               Figure 1.3: Dodonaea viscosa var. angustifolia flowers and leaves (Ebedes, 2015) 
 
Dodonaea viscosa is also called by other common terms like Giant Hop-Bush, Candlewood, 
Sand olive, Native Hop Bush and Sticky Hop-Bush (Anbg, 2006). Common vernacular 
names include ‘mutata-vhana’ and mutepipuna (Harris, 2012). Figure 1.3 shows a picture of 
D. viscosa var. angustifolia leaves and flowers. 
 
Dodonaea viscosa var. angustifolia is an ever-green shrub that grows by spreading or trees 
up to a height of 5 metres long. Its bark is light grey and finely fissured with branchlets that 
are angled to flattened and are usually covered with minute soft hairs. The leaves are droopy 
and shiny light green above and paler green below. It has yellowish green flowers that are 
replaced by yellow or reddish clusters of fruits with papery wings. In a conducive 
environment, DVA needs minimal supervision to grow and produce flowers especially 
during the autumn to winter seasons (Harris, 2012). Dodonaea viscosa var. angustifolia 
flowers are either unisexual or bisexual, with very short filaments and oblong anthers which 
range from 3-3.5 mm in length for males, 2-2.5 in bisexual flowers and might be completely 
absent in females (Walsh and Entwisli, 1996). 
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Australia has approximately 60 species belonging to the genus Dodonaea. The subspecies D. 
viscosa is reported to have seven subspecies which are distinctly geographically located. 
There are two varieties that are mainly found in tropical Africa, the coastal var. viscosa and 
var. angustifolia which is found mainly inland (Turnbull, 1986). Dodonaea viscosa survives 
well in dry, sunny conditions and thrives in sand or loamy soils. It flowers almost throughout 
the year but mainly in summer and spring. They pollinate using the wind and bees which 
have been reported to collect the pollen. The fruits reach full maturity approximately 10-11 
months following flowering (ICRAf, 1992).  
 
In South Africa, the plant has two recognized taxa, D. viscosa var. angustifolia and D. 
viscosa var. viscosa. It is found in abundance from the Western Cape through to the coast of 
Namaqualand, from KwaZulu-Natal to Eastern Cape. In general, the plant is widely 
distributed except for the central part of the country (Harris, 2012). 
 
1.3.1 Biological activity and cultural aspects of Dodonaea viscosa var. angustifolia 
Dodonaea viscosa roots have been reported as having soil-binding properties and are 
effective in controlling soil erosion and stabilization of sand dunes. Dodonaea viscosa var. 
angustifolia is still one of the most widely used medicinal plants especially in rural areas. It 
has several traditional uses which include treatment of stomach aches, measles, influenza and 
colds. Early settlers in the Cape region are said to have made decoctions using DVA leaf tips 
to treat fever. The Khoi-Khoi prepared a concoction using roots to treat influenza and colds. 
Some people gargle using the decoction from leaves for oral thrush and sore throats. In 
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Namaqualand, they boil the leaves, let them steep, strain them and use the extract to treat 
colds, influenza and also induce sweating (Harris, 2012).  
 
The extract from the leaves is also used for conditions like rheumatism, haemorrhoids and 
skin conditions like rash. The leaves also have pain-killing, wound healing and diaphoretic 
(sweat-promoting) qualities and are useful for skin rashes. An alcoholic crude extract from 
DVA leaves has been shown to prevent constriction of coronaries and spasmolytic reflexes 
on smooth muscles and intestines. These alcoholic extracts from DVA are reported to be 
more effective than the aqueous extract in minimizing spasms caused by barium chloride, 
phosphates, histamine acid and acetyl choline (Harbone, 1998). Its leaves are also used as 
painkillers to alleviate pain from toothaches and headaches. Quershi et al (2008) reported the 
treatment of toothaches using a decoction of D. viscosa leaves as a mouth wash by a herbal 
physician. The traditional use of Dodonaea viscosa as a gargle for oral infections was also 
reported by Van Vuuren (2008). It is also common practice in rural areas to use medicinal 
plants as toothbrush sticks for cleaning teeth. The leaf juice is effective in treating trachoma 
and the leaves can be crushed to powder which is used to remove roundworms. Dodonaea 
viscosa var. angustifolia leaves are also used to impart a bitter flavour in beer production 
(Wagner et al., 1987). 
 
Khurram et al (2009) reported that the crude extracts of ethanol, dichloromethane, n-hexane, 
n-butanol, ethyl acetate and aqueous extracts of DVA presented inhibition against 
Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Micrococcus luteus. 
Patel at el (2009) reported activity against C. albicans; the crude extract exerted its effect by 
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inhibiting the adherence of C. albicans cells to oral epithelia which is essential for its 
pathogenicity. Rojas et al (1991) observed that D. viscosa was able to significantly inhibit the 
growth of Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Candida albicans and 
Pseudomonas aeruginosa at a concentration of 20 mg/ml. All parts of D. viscosa were able to 
inhibit the growth of Vibrio cholerae with the maximum zone of inhibition of 26mm being 
observed from the methanol extract (Prakash et al., 2012). 
 
Dodonaea viscosa var. angustifolia crude extract was shown to have time dependent anti-S. 
mutans properties. Sub-therapeutic concentrations of DVA crude extract inhibited 95%, 97% 
and 99% of plaque formation after 6, 24 and 30 hours exposure respectively (Naidoo et al., 
2012). Based on preliminary chemical analysis the authors suggested that polyphenols such 
as catechin, chalcones with trimethoxyphenyl group and tannin with 4-O-β-D-xylopyranoside 
may have been responsible for this anti-plaque characteristic.                                                               
 
Patel et al (2013) reported that crude extracts from DVA significantly reduced acid 
production (P≤0.01) by planktonic S. mutans cells. The acid produced by S. mutans from 
metabolising dietary sucrose is the one responsible for decalcification of teeth leading to 
dental caries. The study aimed to determine which D. viscosa var. angustifolia 
phytochemicals were responsible for its antimicrobial properties against S. mutans. The 
results will justify the potential use of D. viscosa var. angustifolia in the prevention of dental 
caries. 
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1.3.2 Major chemical constituents of DVA 
It is important to know the individual chemical constituents of plants used for medicinal 
purposes. The phytochemical knowledge is essential in optimizing the extraction and 
purification process. It is also important in getting to understand the pharmacological 
relevance and any toxicity the plant might have.  Wagner (2005) mentions the hypothesis that 
any therapeutic activity the plant might have is due to synergistic combinations of various 
chemical constituents rather than single purified compounds. 
 
1.3.2.1 Flavonoids 
Flavonoid refers to a class of non-nitrogenous phenolic pigments that are mainly found in 
plants (Gwin et al., 1986). Figure 1.4 shows the basic structures of common flavonoids. They 
form part of natural antioxidants which are biologically active constituents and contribute to 
the therapeutic characteristics of plants.  Dodonaea viscosa var. angustifolia contains 
bioflavonoids that are therapeutically used to strengthen capillaries and aid blood circulation.  
 
 
  
 
 
 
                   
                 
                Figure 1.4: Basic structures of common flavonoids (Halbwirth, 2010)                                  
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Structurally, flavonoids consist of more than one benzene ring and are derived from parent 
compounds known as flavans (Shanthi et al., 2014). The most common flavonoids in nearly 
70% of the plants are quercetin, quercitrin and kaempferol. The less common groups include 
flavanes, flavones, anthocyanidins, flavonols, proanthocyanidins, catechins and 
dihydroflavones. Most flavonoids are water soluble and frequently occur in plants as sugar 
derivatives called glycosides while those that do not have sugar moieties are called aglycones 
(Doughari, 2012). 
 
 Dodonaea viscosa var. angustifolia (DVA) leaves are reported to contain a prenylated 
flavonoid, viscosol. The plant also contains hautriwaic acid, sakunaretin, 5, 6, 4’-trihydroxy-
3,7-dimethoxy flavones and ent-15,16-epoxy-3ß,8a-dihydroxy-9a-H-labda-13,14-diene. 
Isorhamnetin-3-rhamnosyl galactoside which is usually present in the aerial parts of DVA 
has been shown to lower blood sugar effects (Shanthi, 2014). Methanolic extracts from the 
plant Artocarpus heterophyllus were shown to contain two active isoprenylflavones, 
artcarpacin and artocarpesin. These flavonoids were able to inhibit the growth of cariogenic 
bacteria which included S. mutans and other oral lactobacilli, Actinomyces at a minimum 
inhibitory concentration (MIC) of 12.5-3.13 µg/ml (Palombo, 2009). 
 
Flavonone phytoelaxins isolated from the plant Sophora exigua (Leguminosae) were reported  
to have inhibited the growth of various caries causing bacteria with the active flavonoid 
being 5,7,2,4- tetrahydroxy-8-lavandulylflavanone. The isoflavonoid, erycristagallin isolated 
from the plant Erythrina variegata was shown to inhibit cariogenic bacteria at an MIC value 
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of 1.56-6.25 µg/ml. Its efficacy as an antimicrobial agent was confirmed by the fact that it 
inhibited the uptake of glucose and radio-labeled thymidine in S. mutans (Palombo, 2009). 
 
Using a bioassay guided fractionation technique; the methanolic extract of the bark of Morus 
alba (Moraceae) showed activity against S. mutans and the active ingredient was shown to be 
the flavoinoid, kuwanon G. It proved to be efficient with an MIC value of 8µg/ml against S. 
mutans. This value is comparable to commercially used oral medicines, chlorhexidine and 
vancomycin which have an MIC value of 1 µg/ml.  
 
When time-kill assays were conducted using kuwanon G, a concentration of 20 µg/ml was 
able to completely inactivate S. mutans within a minute. More time-kill assays using other 
bacteria led to the conclusion that kuwanon G showed an antimicrobial activity against 
cariogenic bacteria. Isopanduratin A, a flavonoid compound isolated from Kaempferia 
pandurate also exhibited the same mode of action (Palombo, 2009). 
 
Clinical studies on the toxicity of flavonoids have concluded that they are toxic to 
immortalized cells or cancer cells but they are less toxic or non-toxic to normal cells. 
Research on flavonoids has also shown that they are produced by plants in response to 
infection from microorganisms (Nijveldt et al., 2001). 
 
1.3.2.2 Terpenes 
Terpenes are the most abundant and chemically diverse group of phytochemicals. Figure 1.5 
shows the basic structure of terpenes. Their general formula is (C5H8)n.  Terpenoids exist in 
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liquid form and are mainly found in essential oils and resins (Firn, 2010). They are 
unsaturated, flammable hydrocarbons and are classified according to the number of isoprene 
units they have. Hemiterpenes have one isoprene unit. In fact, the single unit molecule 
isoprene is regarded as the only hemiterpene. Derivatives that contain oxygen, for example, 
isovaleric acid and prenol are considered as hemiterpenes. Monoterpenes have two isoprene 
units. Examples include camphor, menthol and eugenol.  Diterpenes have four isoprene units 
and examples include resins and taxol which is an important anticancer agent (Doughari, 
2012). Another important example of a diterpene is hautriwaic acid which was first isolated 
from D. viscosa leaves in 1936 and was characterized as monohydroxy carboxylic acid. Yen 
Hsti and Yuh Pan Chen determined the full structure in 1970 (Hsu and Chen, 1971).  
Triterpenes are composed of six isoprene units and examples include sterols, steroids and 
cardiac glycosides which possess sedative, anti-inflammatory and cytotoxic activity. 
Sesquaterpenes consist of seven isoprene units and are mainly found in essential oils. They 
exhibit neurotoxic and antimicrobial action. (Doughari, 2012). 
 
Psoralela corylifolia (Fabaceae) a Chinese medicinal plant was reported to contain a 
terpenoid, Bakuchiol which showed activity against both Gram-negative and Gram-positive 
oral bacteria at an MIC value ranging from 1-4 µg/ml. Katsura et al (2001) reported that it 
inhibited S. mutans growth when exposed to different ranges of sucrose concentrations and 
pH values in a temperature dependent manner. Liu et al (2006) isolated ent-rosane 
diterpenoids from Sagittaria sagittifolia (Alismaceae); four of these diterpenoids showed 
antimicrobial activity against S. mutans with MIC values ranging between 62.5 to 125µg/ml. 
The same group of researchers isolated new terpenoids from the plant Sagittaria pygmaea, 
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these were also active against S. mutans and the active compound was shown to be the 
terpenoid β-d-3, 6-diacetoxyglucopyranosyl-ent-kaur-16-ene at an MC value of 15.6 µg/ml. 
Xanthorrhiol a methanolic extract from the plant roots of Curcuma xanthorrhiza 
(Zingiberaceae) was shown to have antimicrobial activity against a range of oral pathogens, 
its efficacy against Streptococcus spp was comparable to that of chlorhexidine at an MIC 
value of  2-4 µg/ml. (Palombo, 2009).  
      
Figure 1.5: Basic structure of terpenes (Kar, 2007) 
 
1.3.2.3 Tannins 
Tannins are high  molecular weight phenolic compounds that are widely distributed in plants 
mainly as glycosides. Figure 1.6 shows the basic structure of common tannins. They are 
mainly found in roots, stem, bark and on the outer layers of the plant tissue. They are soluble 
in both alcohol and water. Their name ‘tannin’ was coined from their characteristic feature to 
tan, that is their ability to produce leather. They are acidic in nature due to the presence 
carboxylic and phenolic groups. Tannins are able to form complex compounds with 
carbohydrates, alkaloids, gelatin, proteins and form a bluish-black colour with Ferric salts 
which are used in ink manufacturing (Kar, 2007). Tannins fall into two main groups, 
condensed tannis and hydrolysable tannins. Water soluble tannins are called egallitannins and 
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gallotannins and upon hydrolysis they produce ellagic acid and gallic acid respectively. 
Tannins are mainly used as antiseptic agents due to their phenolic groups (Doughari, 2012).  
 
Tannin rich formulations from medicinal plants are also used to treat diseases like diarrhea 
and rhinorrhoea. In China, plant extracts with tannins are used to treat burns (Doughari, 
2012). Naidoo et al (2012) reported the presence of the tannin, methyl 4-O-methyl-´a-
xylopyranoside in DVA. Tannins are known to alter the structure of lipids in the cell 
membrane of microorganisms which probably provides them their antimicrobial activity 
(Ishida et al., 2006). 
 
 
                   Figure 1.6: Basic structures of common tannins (Amorim et al., 2012) 
 
1.3.2.4 Saponins  
Saponins are mainly found in the pericarp of the fruits of D. viscosa. Saponin is a term that 
was derived from Saponaria vaccaria (Quillaja saponaria), a plant with a lot of saponins and 
was used as a soap in the olden days. Figure 1.7 shows the basic structure of triterpernoids. 
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Saponins exhibit the same characteristics as soaps in water, they also produce foam. They 
produce an aglycone called sapogenin on hydrolysis and there are two types of sapogenins; 
triterpenoidal and steroidal. Saponins are produced from squalene and structurally consist of 
six isoprene units (Doughari, 2012). 
 
                                 Figure 1.7: Basic triterpernoid structure (Xia et al., 2014) 
 
Various pharmacological properties of saponins have been reported. These include antibiotic, 
antiviral, antifungal, anti-inflammatory, and anti-ulcer properties (Oakenfull, 1981). 
Glycyrrhizinic acid, a saponin found in Glycyrrhiza glabra was shown to have antiviral and 
bacteriostatic properties. Ginsenoside, a triterpene saponin found in ginseng (Panax ginseng) 
is believed to have immune-stimulant activity. Saponins are also used commercially for the 
production of sex hormones (Doughari, 2012).  Soetan et al (2006) showed that crude 
saponin extracts from Sorghum bicolor inhibited the growth of Gram-positive bacteria.  The 
crude saponins extract also showed activity against Staphylococcus aureus, which is a 
pathogenic microorganism to both animals and humans.    
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1.4 Isolation, identification and elucidation techniques 
1.4.1 Liquid Chromatography 
Liquid chromatography is a technique applied to separate a sample into its individual 
constituents. The separation is achieved by interaction of the sample with a mobile and 
stationary phase. There are different combinations of mobile/stationary phases that can be 
used in liquid chromatography; hence it is classified according to the type of phases used. 
The basic principle of chromatography is based on polarity. The components in a mixture are 
separated through a column based on each constituent’s affinity for the mobile phase. The 
principle of ‘like dissolves like’ applies. The components move through the column at 
different rates to achieve separation. Molecules of the same compound generally move as a 
group forming distinct bands during separation. In high performance liquid chromatography 
(HPLC), the bands eluting from the column are detected by means of other instrument 
analysis techniques like UV-VIS spectroscopy (Betancourt and Gottlieb, 2015).  
 
1.4.2 Thin Layer Chromatography 
Thin layer chromatography (TLC) is a technique used to analyze a sample by separating 
compounds in the sample. The TLC technique can help in determining the purity of a 
compound. Thin layer chromatography involves three steps; spotting the plate, developing it 
in solvent and visualizing spots corresponding to constituents. Spotting involves the use of a 
micro pipette to transfer a minute amount of a dilute solution at one end of the TLC plate. 
Thin layer chromatography plates are usually composed of a thin layer of silica gel coated 
onto a metallic or glass sheet. In the next step of development, the end of the TLC that has 
been spotted is placed into a shallow pool of solvent, which moves up the plate. The 
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compounds are separated based on their interaction with the solvent and silica gel. Since a lot 
compounds are colorless, the developed TLC plate is usually sprayed with fluorescent 
material that can be viewed under ultraviolet light. The distance travelled by the solute in 
relation to the solute is used to characterize the different compounds. This is called the Rf 
value. The comparison of these Rf values with those of known compounds can be used to 
identify unknown compounds (Umass, 2016). 
 
1.4.3 Gas Chromatography-Mass Spectrometry 
Gas chromatography (GC) is a widely used technique in various branches of science and 
technology. It plays a huge role in determining the composition and proportions of chemical 
mixtures. However, the GC technique has a limitation in identifying the nature and chemical 
structure of these compounds hence it is attached to a mass spectrometer. The mass 
spectrometer provides the mass ionization value of the compounds, molecular ionization 
peaks of the compounds from the sample, the elemental composition and functional groups in 
cases where high resolution mass spectroscopy is utilized. In some instances, spatial 
isomerism and geometry of the molecules can be identified (Stashenko and Martinez, 2014). 
 
Both liquid and solid samples can be analyzed in gas chromatography systems; the latter 
involves the adsorption of molecules onto a surface, for example, the solid-phase micro 
extraction (SPME) system. During analysis, the sample is first volatilized by exposure to 
high temperatures (200-300°C) and then mixed with the carrier gases, which could be a 
mixture of Helium, Argon, Nitrogen or Hydrogen.  The gas mixture is pumped into the 
separation section which consists of a chromatographic column that is usually composed of a 
fused silica tube that is coated with a thin layer of polymer film.  As the analytes are 
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displaced through the column, the molecules get partitioned between the polymer coated 
stationary phase and the carrier gas which is the mobile phase. They are then separated 
according to their chemical structure. At the end of the column, there is a detection system 
which identifies molecules through thermal conductivity or electron capture and produces an 
electrical signal related to the amount of molecules with the same identity. The data is then 
plotted on a graph which shows the variation of the signal with time and this graph is termed 
a chromatogram (Stashenko and Martinez, 2014). 
 
Gas chromatography-mass spectrometry (GC-MS) is important in phytochemistry in the 
identification and quantification of bioactive compounds. Plant pigments consist of a vast 
number of unknown organic compounds which can be identified by GC-MS through 
interpretation and matching the spectra of those compounds with reference spectra (Ronald, 
1997). 
 
1.4.4 Nuclear magnetic resonance spectroscopy 
Nuclear Magnetic Resonance (NMR) technology is based on the fact that atoms have nuclei 
which possess magnetic properties that can be used obtain chemical information. Research 
groups in the United States first developed the technology in 1946. Over the decades, NMR 
has developed into the principal organic spectroscopy used by chemists to establish detailed 
chemical structures of compounds. The development of stabilized permanent magnet 
technology which allows for high-resolution 
1
H NMR spectra has facilitated the shift from 
research laboratory use only, to industrial environments (Edwards, 2013). 
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The principle of NMR technology uses magnetic properties of atoms. Subatomic particles, 
which are protons, electrons and neutrons, possess quantum energy and spin. The nucleuses 
of some atoms have paired spins which tend to cancel each other out leading to no overall 
spin. These include 
12
C, 
32
S and 
16
O. However, the majority of atoms have nuclei that have 
an overall spin. These include 
1
H, 
19
F, 
31
P and 
13
C. There are set rules used to determine the 
spin of a given nucleus. The nucleus has no overall spin if the number of protons and 
neutrons are even. If the sum of neutrons and protons is odd, the nucleus is said to possess a 
half-integer spin (that is ½, 
3
/2, 
5
/2). If the number of protons and the number of neutrons are 
both odd, the nucleus possesses an integer spin (that is 1, 2, 3) (Edwards, 2013) 
The appropriate radiation frequency necessary for absorption of energy is dependent on three 
factors, nucleus type (e.g. 
13
C or 
1
H), chemical environment of the nucleus (e.g. hydroxyl and 
methyl protons of methanol absorb  differently) and thirdly, the location of the nucleus in 
space if the magnetic field in not uniform everywhere. It is ideal though to have a magnetic 
field that is evenly distributed over the sample as much as possible (James, 1998). 
1.4.5 Infrared (IR) spectroscopy 
Infrared (IR) spectroscopy analysis is based on absorption within the wavelength region of 
infrared light. The infrared region is associated with light that has a longer wavelength and 
smaller energy/frequency than visible light. The signal detected through infrared analysis of a 
sample is then plotted as the percentage transmission of the radiation in comparison to the 
wavelength of the radiation. A downward peak is plotted which represents a specific 
wavelength at which absorption occurs.  Infrared spectroscopy is important in the 
identification of different functional groups within a molecule (Stuart, 2005). 
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1.5 Dental Caries 
Dental caries is a multifactorial, chronic endogenous infection caused by bacteria that is part 
of the normal oral commensal flora. The resulting carious lesion is caused by 
demineralization and destruction of the enamel and later of dentine, by acids produced from 
bacterial fermentation of food debris accumulated inside the oral cavity, specifically on teeth 
surface (Samaranayake, 1996). The actual development of the carious lesion is due to the 
degradation of hydroxyapatites. Initially, enamel demineralization is at balance with 
remineralization, cavitation begins when there is an imbalance in the process whereby 
demineralization occurs faster than remineralization. With the onset of decalcification, the 
infection progresses to affect the dentine tissue leading to inflammation of the pulp and 
eventually its necrosis (Karpisnki and Szkaradkiewicz, 2013). 
 
Dental caries is one of the most prevalent diseases worldwide. Every human is susceptible to 
dental caries throughout their lifetime. It is estimated that 36% of the world population have 
symptoms of dental caries in their permanent teeth and it affects approximately 9% of the 
baby population. There are various factors that promote the onset of dental caries; these 
include biological, environmental, behavioral, physical and lifestyle-related factors. There 
has been a rise in the consumption of dietary carbohydrates in developing countries which 
has correlated with an increase in dental caries (Karpisnki and Szkaradkiewicz, 2013). 
 
Current practices that are used in the fight against dental caries are limited conventional 
preventative methods which are used in combination with restorative procedures. These have 
proven to be insufficient in the control of dental caries. Novel methods of preventing dental 
decay of the primary dentition are constantly being developed (Amin, 2003). Transmissibility 
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of dental caries has also been well documented. It is known that humans do not have 
cariogenic bacteria at birth; probable sources of transmission have been shown to be through 
mouth to mouth kissing and sharing of utensils. The general consensus is that children with 
high counts of mutans streptococci during development of primary teeth have higher chances 
of developing caries in their permanent teeth (Hurlbutt et al., 2010). Extensive research has 
been done on the pathogenesis of dental caries and one fact that has remained constant is the 
important role played by cariogenic bacteria in the development of dental caries. 
 
1.5.1 Pathogenesis of dental caries 
Generally, dental caries presents itself through local demineralization of enamel due to the 
onset of hydroxyapatite degradation.  When oral biofilms are allowed to mature and inhabit 
teeth for extended periods of time, caries lesions develop (Karpisnki and Szkaradkiewicz, 
2013). Dental caries are classified according to the site of lesion. These include, fissure or pit 
caries which are found in molars, premolars and also on the surface of maxillary incisors, 
smooth surface caries which are usually found just below the contact point on approximal 
tooth surfaces, root surface caries, which are found on dentine or cementum when the roots 
get exposed to the external oral environment and recurrent caries which exist where 
restorative procedures have been done (Samaranayake, 1996). Figure 1.8 shows an outline of 
common caries lesions. 
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                                Figure 1.8: Types of caries lesions (Samaranayake, 1996) 
The initial presentation of caries is usually seen as a well demarcated chalky-white lesion 
before the breaching of the enamel continuity. This is termed the ‘white spot’ lesion and it is 
able to heal and re-mineralize due to salivary minerals and fluorides. At this stage the disease 
is reversible. If the lesion progresses, the surface of the teeth become rough and the 
cavitation process ensues. If the cavitation is not controlled, it spreads to the dentine and 
most of the time it leads to destruction of the dental pulp. The main factors involved in the 
development of caries are diet, host factors and plaque microorganisms (Samaranayake, 
1996).     
 
1.5.1.1 Host factors 
Poor oral health care may result in unsatisfactory cleaning of the mouth and receding gums 
that are left unattended, leading to exposure of the roots and increasing susceptibility to 
dental caries development (Schwendicke et al., 2015) The structure of the enamel does not 
have the same mineral content throughout (especially fluoride); some areas of the teeth are 
more prone to develop caries than others (Samaranayake, 1996). Preterm infants tend to have 
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enamel defects which increase their chances of having dental caries (Segura, 2014). The 
mechanical action and flow rate of saliva has been shown to influence caries development. 
Saliva possesses buffering activity; it is able to neutralize acids produced by oral bacteria. Its 
mechanical washing action is efficient in the removal of unattached oral bacteria and food 
debris from the teeth. Saliva also has a high phosphorous and calcium content which are 
essential in the remineralization and healing ‘white spot’ lesions that lead to dental caries 
(Samaranayake, 1996). 
 
There are conditions that limit the production of saliva which include Sjogren’s syndrome, 
diabetes mellitus and cystic fibrosis. Medications like antihistamines and antidepressants also 
decrease the rate of saliva production which increases the risk of caries development (Segura, 
2014). Individuals who smoke are also at a higher risk of developing dental caries as some 
brands of tobacco have high sugar content, increasing susceptibility to caries development 
(Neville et al., 2002). Research has shown that there is a link between smoking and root 
surface caries (U.S. SGA, 2004). 
 
1.5.1.2 Diet 
Diet has a big influence on the development of caries and for years the simplified prevention 
slogan phrase was: ‘don’t eat too much sugar and sugary foods’ (EUFIC, 2003).  Research 
has shown that sucrose rich diets promote the initiation of dental caries. Dental plaques are 
able to utilize sucrose to produce acid and extracellular polysaccharides because sucrose is 
very soluble and diffuses easily through plaque (Samaranayake, 1996). It is important to note 
though that caries levels have decreased over the years but the high consumption of sugar has 
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remained the same. This implies that the effect of sugar in caries development can be 
minimized if good oral hygiene is upheld (EUFIC, 2003). The rate of sugar intake rather than 
amounts that are consumed has been shown to be the decisive factor in caries development. 
The concentration and stickiness of the sucrose consumed determine how long the sugar 
remains in contact with the surface of the teeth. Fructose and glucose also promote dental 
caries but their influence is less than that of sucrose. Xylitol, a polyol carbohydrate is an 
example of a low cariogenic sugar that is being used as an alternative to sucrose 
(Samaranayake, 1996). 
 
1.5.2 Microbiology of dental caries  
Microorganisms form part of the dental plaque, which is a prerequisite for the onset of dental 
caries (Samarayanake, 1996). Approximately 700 different species of bacteria have been 
isolated from the human oral cavity. Extensive research on the oral microbiome has led to the 
conclusion that the Mutans streptococci groups of bacteria are the main factor in the 
development of caries. S. mutans is part of that group of bacteria. The importance of 
Lactobacillus species in further development of dental caries has also been determined. Both 
S. mutans and Lactobacilli spp are aciduric; they grow well in acidic environments and are 
able to rapidly metabolize dietary sugars to organic acids, mainly lactic acid (Karpisnki and 
Szkaradkiewicz, 2013). 
 
 There are various types of microorganisms found in dental lesions. These include many 
obligate and facultative anaerobic bacteria which belong to different genera such as 
Eubacterium, Bifidobacterium, Lactobacillus, Actinomyces, Rothia and Parvimonas. 
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Different groups of bacteria can cause dental caries and these include different members of 
the salivarius, mitis, anginosus groups of streptococci. They are part of plaque bacteria and 
also have inherent biochemical processes factoring in cariogenicity (Karpisnki and 
Szkaradkiewicz, 2013).  Becker et al (2002) reported the presence of S. mutans, 
Streptococcus sanguinis as well as species of Bifidobacterium, Veillonella, Actinomyces and 
Propionibacterium in the oral cavity. 
 
In the 1920’s, a medical microbiologist named Clark reported a bias towards the low pH 
culture media that was being used to grow oral cultures.   He exposed the fact that low pH 
media favoured Lactobacillus growth, which was considered to be the most important caries 
causative organism at that time.  Clark took a different approach and plated his samples at pH 
7. He concluded that early caries lesions were caused by S. mutans. Clark also suggested the 
concept of microbial succession, he observed that different types of bacteria were dominant 
at different stages of caries development, but the main causative organism was S. mutans 
(Russell, 2009).  In that regard, it seems plausible that dental caries may be initiated by 
different combinations of bacteria besides S. mutans and Lactobacillus species. However, 
extensive research on dental caries has revealed that S. mutans is the predominant species in 
the initiation of dental caries and that it is involved in almost all caries lesions 
(Samaranayake, 1996). 
 
1.5.2.1 Streptococcus mutans 
The role of S. mutans in the development of dental caries has been well documented. It is 
estimated that S. mutans is carried by over 98% of adults (Russell, 2009). Mutans 
streptococci is a cluster name that encompasses seven different species; Stretococcus 
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sobrinus, Streptococcus cricetus, Streptococcus mutans, Streptococcus ferus, Streptococcus 
rattus, Streptococcus macacae and Streptococcus downei. These groups of bacteria are 
highly acidogenic and aciduric, they produce acids which dissolve the enamel hence they are 
the most cariogenic pathogens (Samaranayaki, 1996). 
 
1.5.2.1.1 Habitat, Morphology and Growth requirements 
Streptococcus mutans are Gram positive bacteria with thick cell walls that are composed of a 
layer of peptidoglycan (murein) and teichoic acids. These are important in preventing 
osmotic lysis of the cell protoplast and they provide the rigidity needed to maintain the shape 
of the cell. They thrive in environments that range from 18-40 degrees Celsius. Figure 1.9 
shows the colonies of S. mutans. They are also composed of a polysaccharide capsule made 
from dextran glucose subunits. S. mutans have circular DNA and closely interrelated 
plasmids that are about 5.6 kilobases (kb) long. 
 
One of the factors that contribute to the virulence S. mutans in causing caries is its ability to 
attach to teeth surface through the formation of biofilms. It has the ability to adhere to the 
enamel, produce slime and also divide producing micro-colonies within that layer. This leads 
to the formation of biofilms. Adherence to the pellicle of the teeth is achieved by proteins on 
its cell surface. This is followed by its growth while synthesizing the dextran capsule which 
aids in biofilm formation (Todar, 2012). 
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                     Figure 1.9: Streptococcus mutans colonies on blood agar (Morgan, 2015). 
 
Streptococcus mutans are able to breakdown sucrose to glucose and fructose. Fructose is 
fermented to provide energy while glucose is turned into an extracellular dextran polymer 
that is essential for the cementation of S. mutans to the tooth enamel forming a matrix of 
dental plaque. The dextran slime layer provides carbon through the de-polymerization of 
glucose. This process leads to the formation of lactic acid within the plaque which in turn 
dissolves the enamel leading to caries development. Research has shown that S. mutans tend 
to habitat in pits and fissures, and forms 39% of the total streptococci in the oral cavity and 
only 2-9% in the buccal surface (Ikeda and Sadham, 1971). 
 
1.5.2.1.2 Pathogenicity of Streptococcus mutans 
Streptococcus mutans can cause dental caries due to its ability to form biofilm (dental 
plaque) and its ability to produce lactic acid and intracellular polysaccharides. Prior to the 
development of caries, S. mutans is often isolated from the tooth surface and as the infection 
progresses, so do the S. mutans counts. Streptococcus mutans are highly acidogenic, they are 
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able to metabolize dietary carbohydrates, mainly sucrose and glucose to lactic acid and other 
organic acids. Among all the plaque bacteria, S. mutans are able to lower the pH to levels 
critical enough for demineralization more rapidly and are also able to continue acid 
production in that environment making them aciduric. The resulting low pH leads to enamel 
demineralization and eventual tooth decay (Samaranayake, 1996).  
 
Streptococcus mutans also produce insoluble extracellular polysaccharides from sucrose. 
These polysaccharides aid in the formation of biofilms on teeth surface.  The production of 
polysaccharides is catalyzed by three glucosyltransferase isoenzymes. They also produce 
intracellular polysaccharides (IPSs) as glycogen in the presence of extracellular sucrose and 
glucose. The polysaccharide reserves act as food stores which are used when there are low 
amounts of dietary carbohydrates. Research has also shown that S. mutans produce mutacins 
(bacteriocins) which play an important role in its colonization and establishment in dental 
biofilms (Karpisnki and Szkaradkiewicz, 2013). 
 
The main nutritional source for oral bacteria is saliva. Saliva carbohydrate content is 
generally low; however these levels are increased up to about a 1000 fold after a meal. 
Streptococcus mutans and other oral bacteria have developed regulatory mechanisms that 
fully exploit these transient increases in carbohydrates. The initial step is the intake of sugar 
into the organisms. The second step is the breakdown of these carbohydrates through the 
glycolytic pathway. This stage is critical in the aetiology of dental caries as the acids 
produced lead to enamel demineralization (Todar, 2012).  
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In general, bacteria use the Embden-Myerhof pathway to degrade glucose and produce two 
pyruvate molecules per molecule of glucose. Depending on the existing sugar levels, 
Streptococcus mutans convert pyruvate to ethanol, formate and acetate under low sugar 
conditions and in excess sugar levels, pyruvate is converted to lactate molecules leading to a 
fall in pH. This fall in pH is followed by a rise back to its original value in about an hour, 
giving rise to what is termed the ‘Stephan curve’ (Samaranayake, 1996). Figure 1.10 gives an 
outline of the Stephan curve. 
 
Figure 1.10: The Stephan Curve (Deery and Toumba, 2015). 
 
1.5.3 Management of dental caries 
Dental caries is an endemic disease. There is potential to prevent or even cure the disease 
through early diagnosis and subsequent arrest or reversal of the caries process (Alfano et al., 
2001). Saliva plays a huge role in preventing caries development. There are also some major 
approaches that have proved to be successful in the prevention of dental caries. Most are 
based on the alteration of diet, use of anti-cariogenic agents and protecting susceptible areas.  
 
 
 
35 
 
1.5.3.1 Saliva 
The fact that the human tooth lacks its own regulatory mechanism to shed dead surfaces 
makes it vulnerable to plaque development (Katz, 2015). Saliva plays a huge role in the 
prevention of dental caries by maintaining some form of equilibrium in the oral cavity. Saliva 
is composed of proteins, water, mineral elements, electrolytes which determine its pH and 
organic elements such as immunoglobulin and mucin which are essential for its biological 
properties. The immunoglobulins and salivary enzymes like amylase hinder the growth, 
adherence and aggregation of micro-organisms. The presence of mineral elements like 
phosphates, carbonates together with urea enables its ability to regulate pH, thereby 
preventing sustained low pH values that promote caries development (Fakhoury and Peraldi, 
1996). The washing action of saliva enables its effect as a lubricant and aids in the washing 
of bacteria from the oral cavity hence limiting their effect.  
 
1.5.3.2 Diet 
Metabolism of dietary carbohydrates by oral flora is the initial stage in the development of 
dental caries. Research has shown that the major factor in the initiation of the disease is the 
rate of consumption of carbohydrates rather than the amount between meals. The stoppage or 
reduction of carbohydrate consumption between meals reduces the amount of fermentable 
sugars that can be accessed by oral flora (Samaranayake, 1996). Use of non-cariogenic 
artificial sweeteners that are not be easily absorbed and fermented by plaque bacteria is 
another good alternative. Artificial sweeteners in the market include sorbitol, lycasin and 
xylitol (NIH, 2001). 
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1.5.3.3 Antimicrobial agents 
There are some antimicrobial agents available commercially that are used to prevent dental 
caries. Examples of these include oral rinses like iodine, chlorhexidine, triclosan and 
essential oils. Some of these antimicrobial agents are incorporated into tooth pastes and 
include polymers, and surfactants that have the ability to reduce biofilm. 
 
1.5.3.3.1 Fluoride 
Research data on fluoridation of water and dentifrice material has proved to be effective 
(Alfano et al., 2001). There are various ways in which fluoride can be delivered to teeth. It 
can be administered in early childhood by its inclusion during an amelogenesis. The most 
effective way is via the pipe-borne water supply at 1 ppm. Other ways of delivery include 
fluoridated tooth paste; fluoridated gel preparation which are topically applied and use of 
tablets (NIH, 2001) Fluoride ions exert their effect by forming flouroapatite through the 
substitution of hydroxyl groups from hydroxyapatite. Flouroapatite is less susceptible to 
being dissolved by acid. Fluoride also aids in remineralization of caries cavities in enamel 
and also interferes with plaque metabolism by limiting glycolysis thereby inhibiting the 
production of intracellular polysaccharides (Samaranayake, 1996).  
 
1.5.3.3.2 Chlorhexidine 
Chlorhexidine is an antimicrobial agent widely used by most dental professionals in the 
prevention of oral diseases. It is used as the active ingredient in oral rinses to reduce dental 
plaque and bacterial build up in the oral cavity. It is also delivered in the form of gels and 
recently, it is applied as a varnish layer to protect teeth enamel. Its bactericidal action is 
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immediate and exhibits prolonged bacteriostatic activity. This prolonged bacteriostatic 
activity characteristic is due to the fact that chlorhexidine adsorbs onto the pellicle coat of 
teeth enamel.  Chlorhexidine gluconate solution (0.12%), which is a combination of 
chlorhexidine and gluconic acid is used to treat oral diseases and promote regeneration of 
oral tissues (Jenkins et al, 1988).  
 
However, prolonged use has been shown to have adverse effects. It can cause teeth, tongue 
and gingiva staining. Reduced bitter and salty taste sensations can also be experienced with 
time. Tooth staining is caused by the breakdown of bacterial membrane and subsequent 
denaturation of their proteins (Helms et al., 1995). Disulfide ions are also reduced to thiol 
ions which then react with salivary iron (III) ions to form dark complexes (Gilbert, 2006). 
Some researchers have argued the efficacy of chlorhexidine in the prevention of dental caries 
claiming that the clinical data is not conclusive (Alfano et al., 2001). 
 
1.5.3.3.3 Iodine  
Use of iodine solutions as topical applications has been shown to be effective in the 
suppression of oral S. mutans. A study on the use of iodine in dentistry indicated that the 
application of 0.2% potassium iodine solution (KI) in humans enabled the elimination of S. 
mutans from reachable tooth sites for a period of 13 weeks after treatment (Gibbons et al, 
1974). Caufield and Gibbons (1979) reported a similar result being observed for 20 to 24 
weeks following treatment with 2% iodine-potassium iodide solution. Povidone-iodine (PVP-
I) is an effective antimicrobial agent compared to other iodine solutions. The combination of 
PVP with iodine increases its solubility in both water and alcohol. It also reduces the staining 
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effect of iodine on teeth. The target sites of iodine are located in the bacterial cytoplasmic 
membrane and cytoplasm. Its microbial killing action is instant (Amin et al., 2004). 
 
1.5.3.3.4 Triclosan 
The incorporation of triclosan in toothpaste and its ability to enhance the antimicrobial 
effects of toothpaste has been well documented. In a study titled the ‘Chochrane Review’, 
researchers concluded that continual use of fluoride toothpaste containing triclosan resulted 
in a 22% reduction in dental plaque when compared to triclosan free fluoride tooth paste. 
They also concluded that it exhibited a 41% reduction in plaque development when 
compared to triclosan free fluoride tooth paste (Riley and Lamont, 2013). Davies et al (2004) 
stated that dentifrice which contained triclosan provided a more effective control of dental 
plaque development compared to conventional fluoride dentifrice. There are some studies 
however that have shown that triclosan adversely affects the immune system and children 
exposed to triclosan containing products exhibited more hay fever and allergy symptoms. 
Some bacteria exposed to triclosan also develop resistance with time (Paleo Personal Care, 
2015). 
 
1.6 Anticariogenic activities of plants 
 
The importance of effective antimicrobial agents in the prevention of dental caries has been 
well-documented. Medicinal plants have been shown to confer significant antimicrobial 
activity against dental caries causing bacteria, S. mutans. Chloroform extracts from the aerial 
parts (leaves) of the plant Drosera peltata which is used traditionally to treat dental caries, 
were shown to have an MIC of 31.25 µg/ml against S. mutans. Phytochemical analysis of the 
plant showed that plumbagin was the active compound (Didry et al, 1998). Aqueous 
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propanone extracts of red grapes were shown to have antimicrobial activity against S. mutans 
with an MIC of 500 µg/ml. From the same study they also observed that various plant 
propanone extracts were able to inhibit adhesion of S. mutans to glass (Smullen et al, 2007). 
 
Ethanol extracts from Helichrysum italicum flowers, a plant mainly found by the 
Mediterranean region was shown to have antimicrobial activity against S. mutans and S. 
sobrinus with MIC values ranging from 31.25 to 62.5 µg/ml (Nostro et al, 2004). The 
compound Malvidin-3,5-diglucoside was confirmed to be the active constituent of the plant 
Alcea longipedicellata with  MIC values of 160-200 µg/ml against cariogenic oral 
streptococci. Macelignan, a compound isolated from Myristia fragans was shown to have 
significant antimicrobial activity against S. mutans with an MIC value as low as 3.9 µg/ml. 
Its activity can be compared to Chlorhexidine and it is effective compared to other 
phytochemical anticariogenic agents. Macelignan also inhibited biofilm formation by S. 
mutans (Rukayadi et al, 2008).  
 
The potential use of DVA in the prevention of dental caries has been documented. Naidoo 
(2012) reported a decrease in biofilm formation by S. mutans after exposure to subinhibitory 
concentrations of DVA. After exposing S. mutans for 6, 24 and 30 hours to the crude DVA 
ethanol extract in a biofilm assay, the bacterial counts were reduced by log 1.3, 0.95 and 1.95 
respectively. The author also observed a significant reduction in acid production by S. 
mutans over a 16 hour period when exposed to subinhibitory concentrations of DVA. 
However, like most studies done to investigate the traditional use of medicinal plants, the 
potential use of DVA in preventing dental caries has been limited to the use of crude organic 
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or aqueous solvent extracts and the chemical constituents responsible for the anticariogenic 
property have not been identified. Therefore, the aim of this study was to identify the 
anticariogenic chemical constituents present in D. viscosa var. angustifolia and establish its 
safe use in preventing growth of S. mutans and dental caries.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
 
1.7 Aim 
The aim of this study was to identify the anticariogenic chemical constituents present in D. 
viscosa var. angustifolia and establish its safe use in preventing growth of S. mutans and 
dental caries.  
 
1.8 Objectives  
 To analyse crude leaf extracts using thin layer chromatography to identify the groups of 
chemicals present 
 To further separate and identify selected groups of chemicals using liquid 
chromatography, gas chromatography-mass spectrometry (GC-MS) and finally elucidate 
the structure of isolates using Nuclear Magnetic Resonance (NMR) spectroscopy and 
Infrared (IR) spectroscopy. 
 To determine minimum inhibitory concentrations (MIC) and minimum bactericidal 
concentration (MIC) of newly isolated and identified chemicals against S. mutans 
 To determine the inhibitory effect of sub-inhibitory concentrations of newly isolated and 
identified chemicals on acid production and biofilm formation by S. mutans 
 To investigate the cytotoxic effect of newly identified beneficial chemical/s  
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                                            CHAPTER 2 
Methods and Materials 
2.1 Cultures 
Saliva and periodontal pocket debris samples from patients attending the Wits Oral and 
Dental Clinic at Charlotte Maxeke Johannesburg Academic Hospital were previously 
collected (Ethical clearance number M10205) and cultured on Mutans Bacitracin agar to 
isolate S. mutans. Streptococcus mutans cultures were then identified using cultural 
characteristics and a series of biochemical reactions using the Analytical Profile Index (API) 
20 Strep standardized system (BioM`erieux, SA). Cultures were then stored at −70oC.  
Streptococcus mutans ATCC 10923 and a clinical strain termed SM 1 were used in the study.  
 
2.2  Plant material 
Plant material was collected from the Pypeklipberg, Mkhunyane Eco Reserve in 
Mpumalanga province of South Africa. Figure 2.1 shows the D. viscosa var. angustifolia 
leaves after drying and grinding them to powder. 
 
 
 
 
 
 
             Figure 2.1: Dodonaea viscosa var. angustifolia dry leaves and powder 
 
 
43 
 
The plant was positively identified by Mrs. Ranee Reddy, a taxonomist from the Herbarium 
at the University of the Witwatersrand. It was identified as D. viscosa var. angustifolia Benth 
which belongs to the Sapindaceae Family. Voucher specimens number J 94882, were 
previously deposited at this Herbarium (Patel and Coogan, 2008).         
 
2.2.1 Extraction 
Dried D. viscosa var. angustifolia leaves were first milled to a powder (Figure 2.1). The 
crude extracts were prepared using a method described by Eloff, (1999). Sixty grams of 
powder was mixed with 600 ml of methanol in a closed container, agitated for 72 hours and 
centrifuged at 5000 rpm for 20 minutes. The supernatant was then collected in pre-weighed 
100 ml beakers. The procedure was repeated three times with the same powder. All the three 
supernatants were then pooled together in the same beaker and the methanol was allowed to 
evaporate under a cold air stream. The beaker with the dried extracts was weighed again to 
calculate the extract yield.  
 
2.3 Column Chromatography 
Column chromatography was done to fractionate the dry methanol extract. Sequential 
fractionation was carried out using a chromatography column packed with a slurry of 
activated silica gel with mesh ranging from 70 to 230Å (Merck®). The slurry was prepared 
using 100% hexane. The methanol extract was then dissolved in a 50% v/v mixture of ethyl 
acetate and hexane. The sample was then loaded onto the silica gel column. Elution was 
started with hexane (100%). This was followed by increasing gradient polarity through the 
addition of ethyl acetate up to 100%.  Table 1 gives an outline of the solvent system used for 
elution.  
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Table 2.1: Solvent gradient used for elution. Analytical grade chemicals from Merck® and 
Sigma® were used. 
Solvent Proportion (%) 
Hexane 100 
Hexane/ethyl acetate 90:10 
Hexane/ethyl acetate 80:20 
Hexane/ethyl acetate 70:30 
Hexane/ethyl acetate 30:70 
Ethyl acetate 100 
Ethyl acetate/methanol 70:30 
 
Fractions were collected in 10 ml vials and were pooled together according to their thin layer 
chromatography profiles. A total of six fractions labelled fraction 1 to 6 (F1-F6) were 
collected as represented in Figure 2.2. 
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Figure 2.2: Schematic representation of fractions isolated from D. viscosa var. angustifolia 
leaves using column chromatography 
 
 
2.4 Thin layer chromatography (TLC) 
Thin layer chromatography plates from Merck® (Silica gel 60 F254) were used to analyse 
fractions collected from column chromatography according to a technique described by 
Methanol Fraction 
6.8g 
Silica gel 60A (70 to 230mesh), Gradient based 
elution 
 Fraction 1 
920 mg 
(Yellow) 
100% Hex 
 
Fraction 2 
840 mg 
(Green) 
Hex:EtAc 
    80:20 
Fraction 4 
60 mg 
(Green) 
Hex:EtAc 
   50:50 
Fraction 5 
780 mg 
(Orange) 
Hex:EtAc 
    30:70 
Fraction 6 
1550 mg 
(Yellow) 
EtAc:Meth 
     70:30 
Fraction 3 
1950 mg 
(Yellow) 
Hex:EtAc 
    70:30 
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Kotze and Eloff (2002). Fifty milligrams of the individual fractions were dissolved in 1 ml of 
solvent (ethyl acetate) and spotted on a line drawn by pencil at one end of the silica gel plate. 
The TLC plates were then developed using three different solvent systems of polarity 
containing the mobile phases, toluene/ethanol/ammonium hydroxide (18:2:0.2) [TEA], 
dichloromethane/ethyl acetate/formic acid (10:8:2) [DEF] and ethyl acetate/methanol/water 
(40:5.4:5) [EMW]. Thin layer chromatography plates were placed in closed tanks in such a 
way that the end near the sample application area was in contact with the mobile phase. The 
chromatograms were then allowed to run for 15 min after which they were dried with a cold 
air stream. The dry TLC plates were then developed by spraying with the vanillin reagent 
(0.2 g vanillin + 28 ml methanol + 1 ml sulphuric acid), then dried and placed in an oven at 
100°C for optimal colour development.  The distance each band travelled was compared to 
the distance travelled by the solvent reported as the Retention factor (Rf): 
   
                           
                           
 
Each compound has a characteristic Rf for a particular solvent. 
 
2.5  Preliminary screening for antimicrobial activity 
2.5.1 Contact Bioautography 
Contact bioautography is a technique used to screen for active compounds on thin layer 
chromatography plates. A technique described by Suleiman et al (2010) was used in the 
study with some modifications. The six individual fractions were dissolved in methanol at 10 
mg/ml. These were then loaded onto TLC plates on a line drawn by pencil in a narrow band. 
Three solvent systems previously described were used to elute the bands, 
 
 
46 
 
toluene/ethanol/ammonium hydroxide (18:2:0.2) [TEA], dichloromethane/ethyl 
acetate/formic acid (10:8:2) [DEF] and ethyl acetate/methanol/water (40:5.4:5) [EMW]. The 
plates were then dried under a cold air stream for a week to remove any excess solvent left. 
One day old S. mutans cultures (ATCC 10923) grown on Blood Agar media were used. 
Using a sterile swab, these were then transferred into 100 ml of freshly prepared Tryptone 
Soya Broth media. The suspension was then centrifuged at 5000 rpm for 15 minutes. The 
supernatant was then discarded. The remaining bacterial pellet was then mixed with 50 ml of 
semi-solid Columbia Agar media and vortexed. The dry chromatograms were then covered 
with a layer of semi-solid media with bacterial cultures and stored at 4°C for an hour to allow 
the bands to diffuse into the media. The plates were then incubated for 24 hours at 37°C in a 
humidified CO2 jar. After incubation, the TLC plates were sprayed with a solution of p-
iodonitrotetrazolium violet (INT) (Sigma®) at 2mg/ml. Areas with growing organisms 
turned pink after incubation from reduction of the dye while zones of inhibition were clear. 
This indicated fraction bands with antimicrobial activity. These clear zones were then 
compared with reference plates to identify the Rf values of active compounds.  
 
2.6 Minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC) assays 
 
Minimum inhibitory concentration and minimum bactericidal concentration tests were 
performed. Hundred microliters of double dilutions of constituent plant extracts in dimethyl 
sulphoxide (DMSO) were added to each well of a 96-well round bottom microtitre plate in 
varying initial concentrations (25 – 0.0125 mg/ml. Colonies of bacterial cultures were 
emulsified in Tryptone Soya broth to achieve bacterial counts of approximately 10
7
CFU/ml 
by adjusting the optical density to 0.2 at 405nm. These suspensions were used as inoculum. 
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Addition of inoculum diluted the plant extracts by half. Hundred microliters of inoculum was 
transferred into each well of the microtitre plate and incubated anaerobically for 48 hours at 
37°C. Dimethyl sulphoxide (DMSO) was used as a solvent and as a control vehicle. 
Chlorhexidine gluconate, an antimicrobial chemical used for oral hygiene was used as a 
positive control. After incubation, the lowest concentration that inhibited visible growth was 
recorded as the MIC. Each dilution was then sub-cultured on blood agar to detect viable 
bacteria and to determine the MBC  
 
2.7 Effect of chemical constituents on biofilm formation by S. mutans 
The effect of individual fractions on biofilm formation by S. mutans was tested using D. 
viscosa var. angustifolia fractions according to a technique described by Limsong et al 
(2004) with some modifications. Sterile 10 ml bijou bottles with two sterile glass slides (25 
mm x 12 mm) in an upright position (90
o
) were prepared. In one bottle (control), only 2 ml 
Tryptone Soya broth was added. While in the test bottles, 2 ml Tryptone Soya broth 
containing sub-inhibitory concentration of the constituent plant extract was added. Hundred 
microliters of S. mutans inoculum was added to each bottle and incubated. Biofilms were 
grown anaerobically at 37
o
C.  One glass slide from each of the bottles was removed after 6 
hours and rinsed with phosphate buffered saline (PBS) to remove unattached bacterial cells. 
The attached cells were aseptically scraped off the slides using sterile slides, re-suspended 
and vortexed in 2 ml PBS. Ten-fold serial dilutions were prepared and 100 µl of each dilution 
was spread on blood agar. The plates were incubated for 48 hours at 37
o
C under CO2. The 
numbers of colonies were then quantified and the counts multiplied by the dilution factors to 
determine viable bacterial count. The same procedure was repeated for the second slides after 
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24 hours. For preliminary screening, these experiments were done using three different 
subinhibitory concentrations from each fraction and crude extract. After purification of the 
bioactive subfractions, the biofilm tests were done using the same technique and were 
repeated three times per concentration using each of the S. mutans strains. The bacterial 
counts were compared using the Wilcoxon rank-sum test (Mann-Whitney).  
 
2.8 Effect of chemical constituents on acid production by S. mutans 
The effect of individual fractions on the acid production by planktonic cells of S. mutans was 
studied using a technique described by Nalina and Rahim, (2007) with some modifications. 
Tryptone Soya broth (4 ml) containing sub-inhibitory concentration of plant extracts was 
inoculated with 100 µl of culture containing 10
7 
CFU/ml of S. mutans determined by 
adjusting the optical density to 0.2 at 405 nm. Similarly, Tryptone Soya broth (4 ml) without 
extract was inoculated with 100 µl culture of S. mutans as a control. The tubes were 
incubated at 37
o
C under CO2. The pH was read at 0 hours, 8 hours and then every 2 hours for 
a total exposure period of 20 hours. The bacterial count was done at 0 hours, 8 hours and 10 
hours using serial dilution techniques. For preliminary screening, these experiments were 
done using three different subinhibitory concentrations from each fraction and crude extract. 
After purification of the bioactive subfractions, the acid tests were done using the same 
technique and were repeated three times per concentration using each of the S. mutans 
strains. The pH values of the control and tests were then compared for each time interval 
using the Wilcoxon rank-sum test (Mann-Whitney). 
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2.9 Purification and identification of fractions showing antimicrobial activity 
2.9.1 Liquid chromatography (LC) analysis 
After a series of antimicrobial tests, fraction five (F5) exhibited the most significant activity 
and was chosen for further purification through liquid chromatography. The Cheetah™ MP 
100 Flash purification system supplied by Bonna-Agela Technologies was used for liquid 
chromatography.  Two millilitres of sample was injected for each run. Elution was done 
using a solvent gradient phase of Hexane/Ethyl acetate. Normal phase chromatography was 
done using silica gel columns. Equilibration of the column was done using a solvent ratio of 
90% Hex: Ethyl acetate 10%. The flow rate was set at 10 ml per minute. The peaks were 
viewed at 270nm. Compounds in the sample had different retention times, which is the time 
taken between sample injection and a compound reaching a detector at the end of the column. 
The eluates were collected in 10 ml test tubes and combined according to their TLC profiles. 
 
2.9.2 Gas Chromatography-Mass Spectrometry (GC-MS)  
After liquid chromatography analysis and another round of antimicrobial assay tests, two sub 
fractions were chosen (F5.1 and F5.2) for GC-MS analysis. Gas chromatography-Mass 
spectrometer analysis was done using an Agilent Technologies 5190-2293 gas 
chromatography machine with an HP-5ms ultra inert column (30 m x 250µm x 0.25 µm) 
interfaced with the Agilent Technologies 19091S-433UI mass spectrometer. The initial 
temperature was set at 50°C and increased at a rate of 5°C per minute up to the set limit of 
310°C. The split ratio was set at 1:50 and helium was used the carrier gas. The auxiliary 
transfer port was set at 280 °C. The ion source (EI) temperature was set at 230 °C with fixed 
electron energy set at 70 eV. Solvent delay was set at 3 minutes. Mass spectra and the 
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different retention times were used to identify the compounds through comparison with a 
catalogue in the Wiley 275 library of compounds.  
 
2.9.3 Nuclear Magnetic Resonance Spectroscopy 
 
Nuclear magnetic resonance spectroscopy was done to determine the structure of the 
compound. 
 1
H NMR and 
13
C NMR spectra were all recorded using the Bruker AVANCE 
500 spectrophotometer. All spectra were recorded in DMSOd6. The chemical shift values in 
all spectra obtained are reported in parts per million and referenced against the internal 
standard, TMS, which occurs at zero parts per million, in the case for 
1
H NMR spectra. For 
13
C NMR spectra, all chemical shift values are relative to the central signal of DMSOd6, 
which occurs at 2.45 parts per million. 
 
2.9.4 Infrared spectroscopy analysis 
Infrared analysis was done using the Perkin Elmer FT-IR 100 spectrometer. Ten milligrams 
per milliliter of subfraction 5.1 was dissolved in ethyl acetate. A small pipette tube was used 
to draw up the sample from which one drop was placed on the surface plate for analysis. 
 
2.10 Cytotoxicity  
Cytotoxicity tests were carried out to investigate the effect of identified potential 
anticariogenic compounds on human cells. Human embryonic kidney cells (HEK 293) 
previously frozen at - 80°C were used.  
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2.10.1 Cell culture passaging 
The HEK 293 kidney cell line was routinely sub-cultured and supplemented with fresh 
medium to cultivate the cells. Dulbeco’s modified eagle’s medium (88%) supplemented with 
fetal calf serum (10%), L-glutamine (1%) and penicillin/streptomycin (1%) was used for 
culturing the cells. Old cell culture medium was first removed from T75 tissue culture flask. 
Two milliliters of PBS which had been warmed to 37°C was then added to each T75 flask to 
remove the excess medium and dead cells. After discarding the PBS, 2 ml of Trypsin EDTA 
was added for cell dissociation. The flasks were incubated at 37°C for 2 minutes. After 
incubation, the flasks were given a slight knock to aid dissociation of cells and to prevent 
clumping of cells. Two milliliters of culture medium was then added to the flasks to 
neutralize trypsin. Two milliliters of resulting cell suspension was transferred to each new 
T75 flask which was cultured for stock purposes. In the case of T25 flasks, 1 ml was 
transferred. T25 flasks were used for the cytotoxicity assays. Each T75 flask then received 8 
ml of fresh medium and the T25 flasks received 4 ml of medium each. These were then 
incubated at 37°C under CO2. 
 
2.10.2 Cytotoxicity assay 
The cytotoxicity of subfraction 5.1 which had the highest antimicrobial activity and crude 
extract were tested using the 3-(4,5-dimethyl  thiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) assay technique. The method is based on the ability of the mitochondrial enzyme 
succinate dehydrogenase from viable cells to reduce MTT into an insoluble purple product 
called formazan (McCauley, 2013). Human embryonic kidney (HEK) 293 cells were first 
harvested by trypsinizing the monolayer cell culture grown in T25 tissue culture plates.  
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2.10.2.1 Determination of cell count and viability 
Cell numbers and viability were determined using the Trypan blue method. Twenty 
microlitres of HEK 293 cells in medium were mixed with 20 µl of Trypan blue inside a vial. 
Twenty microlitres of this mixture was placed onto a hemocytometer and spread with a 
cover-slip. Viable cells were counted from the heamocytometer quadrants using a light 
microscope at x1000 magnification. The number of viable cells needed to get the desired 
concentration of 111000 cells per ml was then calculated using the following equation:  
             
                     
 
            
The cell number was then multiplied by the amount of cell suspension needed to fill the 
applicable wells of a 96 well microtitre plate (McCauley et al, 2013). 
 
2.10.2.2 Seeding of cells into the microtitre plate and exposures 
Cytotoxicity tests were done from three separate T25 plates in triplicate using 96 well 
microtitre plates.  A hundred microlitres of media only was added to form blank test control 
wells.  The blanks were added to eliminate any interference that might happen during reading 
of the absorbance values for test wells. Two percent Triton-X was used as a positive control.  
Dimethyl sulphoxide (DMSO) was used to dissolve the crude extract and subfraction 5.1 
hence a DMSO control was added by pipetting 100 µl of the cell solution and later adding 
100µl of 1% DMSO. Cell culture controls were also included by pipetting 100 µl of the cell 
solution. A hundred microlitres of cell suspension was then pipetted into applicable wells to 
form the sample test wells.  The microtitre plates were then incubated for 24 hours at 37°C 
under 5% carbon dioxide. 
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After 24 hours of incubation, the tissue culture flasks were viewed for cell growth under the 
microscope at x1000. The cells had grown and attached to the surface. Media was removed 
from the plates and replaced with 100 µl of fresh medium. Serial dilutions of the crude 
extract and subfraction 5.1 were prepared using DMSO diluted with PBS to make 1% 
DMSO.  Hundred microlitres of each sample dilution was added in triplicate to the test wells.  
Each sample well had 0.5 % DMSO.  The concentrations of the crude extract and subfraction 
in the test wells ranged from 25 mg/ml to 0.0125 mg/ml.  Hundred microlitres of 1% DMSO 
was also added into the DMSO control wells. Two percent Triton-X was added to the 
positive control wells. The plates were then incubated for 24 hours at 37°C and 5% carbon 
dioxide. 
 
After incubation, the media with the test samples and controls was removed and replaced 
with 100 µl of the MTT reagent. The plates were further incubated for 3 hours at 37°C and 
5% carbon dioxide. The MTT reagent was pipetted out and replaced with 100% DMSO to 
dissolve the formazan crystals. After 30 minutes of incubation, the plates were read with a 
spectrophotometer at 570 nm. 
 
Figure 2.3 gives an outline of the steps taken from extraction, identification and elucidation 
of the bioactive constituent up to investigating its level of cytotoxicity on human cells. 
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Figure 2.3: Summary of the screening process up to elucidation of the bioactive compound 
Methanol crude 
extract 
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                                           CHAPTER 3 
                                                       Results 
 
3.1  Dodonaea viscosa var. angustifolia crude methanol extract yield  
 
Dodonaea viscosa var. angustifolia (DVA) leaves that had been dried and crushed into 
powder were serially extracted with methanol. Extracts were combined, dried under vacuum 
and weighed to calculate the yield per given mass of dried leaves. Table 3.1 shows the 
percentage yield of the methanol extractions. 
 
Table 3.1 Percentage yield from the dry weight of DVA methanol extract 
No. of methanol 
extractions 
Mass of DVA 
leaves (g) 
Yield (g) Yield (%) 
1 60 g 3.7 6.18 
2 60 g 3.1 5.17 
Total yield   6.8 11.4 
 
 
Methanol was chosen as a solvent because of its amphiphilic property. It consists of both 
water soluble and water-insoluble groups which makes it ideal in dissolving both polar and 
non-polar compounds in plant extracts. It also has a low boiling point which makes it ideal 
for extraction and concentration of bioactive compounds. The extracts were combined and 
weighed and a percentage yield of 11.4% was obtained. Column chromatography was used 
as the first step to fractionate the crude extract. 
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3.2  Column chromatography 
Silica gel chromatography columns were used to fractionate the dry methanol extract. A 
solvent gradient ratio of hexane and ethyl acetate was used. A total of 9 fractions were 
obtained. These were combined according to their TLC profiles to give 6 major fractions 
(F1-F6). Figure 3.1 gives an outline of the fractions and yield. 
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Figure 3.1 Schematic representation of fractions isolated from the D. viscosa var. 
angustifolia leaves using column chromatography 
 
Fraction 1 was eluted with 100 % hexane and had deep red-orange colour which is typical of 
the non-polar β-carotene compounds. Fraction 2 was eluted as a green band from the column 
which could have been the chlorophyll group of compounds. Fraction 3 was eluted with a 
more intermediate polar solvent and was the most collected of all fractions with a mass of 
1950 mg after drying. Its colour and polarity was typical of xanthophylls or phaeophytin 
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group of compounds. Fraction 5 and 6 were eluted with polar solvents and had a deep yellow 
colour which is typical of polar flavonoids. All fractions were dried and weighed.  
 
3.3 Thin layer chromatography (TLC) of the methanol extract 
Dried methanol fractions from column chromatography were reconstituted to 10 mg/ml, 
spotted and ran on TLC.  Figure 3.2 shows TLC profiles of the six fractions and the crude 
extract. 
 
 
 
Figure 3.2: TLC plates of the D. viscosa var. angustifolia crude extract and six fractions 
after development with 10 % v/v aqueous sulfuric acid 
 
 
 
Different bands of 
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under daylight 
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Three solvent systems were used, ethylacetate:methanol:water EMW(40:5:4.5), 
tetrahydrofouran:ethylacetate:formic acid TEF(10:8:2),  and toluene:ethanol:ammonium 
hydroxide TEA (18:2:0.2). The TEA solvent combination was able to separate non-polar 
fractions, 1 and 2 with band Rf values ranging from 0.15 and 0.96. Fractions 3 and 4 were run 
with an intermediate polar solvent combination, TEF, with fraction 4 having the highest band 
Rf value of 0.88. Fractions 5 and 6 were separated with EMW with Rf values ranging from 
0.03 to 0.56. The crude extract was separated with TEA at a concentration of 10 mg/ml. Most 
of the bands were visible in daylight. Those not visible in daylight were viewed under 
ultraviolet light at 365 nm.  
 
3.4 Contact Bioautography 
Preliminary antimicrobial activity against S. mutans of the six fractions was analyzed using 
the bioautography assay technique.  Figure 3.3 shows the autobiograms of the six fractions. 
  
 
Figure 3.3: TLC bioautograms of the fractions and D. viscosa var. angustifolia crude extract 
after incubating them with a layer of semi-solid media with S. mutans cultures and spraying 
with INT dye 
**Zones of inhibition.  
        Rf values: 
Fraction 1- 0.96 
Fraction 5- 0.17, 0.19 
Fraction 6- 0.19, 0.26 
Crude extract- 0.15, 0.20, 0.23  
Fraction 5 had the 
biggest zone of 
inhibition with a 
diameter of 6mm 
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Clear areas indicating bacterial inhibition were compared with reference TLC plates using Rf 
values of the bands to identify compounds with antimicrobial activity. Fraction 1, 5, 6 and 
the crude extract exhibited zones of inhibition. Fraction 5 had the most active compound as 
indicated by a bigger zone of inhibition (6 mm) at Rf value 0.17 compared to the other 
fractions. This preliminary screening showed that fraction 5 was the most bioactive fraction. 
Therefore fraction 5 was further fractionated and subfractions 5.1 and 5.2 were obtained 
(Figure 3.4). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Schematic representation of subfractions isolated from the fraction 5 of D. 
viscosa var. angustifolia leaves using column chromatography 
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3.5 Antimicrobial activity assays of fractions (Preliminary screening)  
 
All the six D. viscosa var. angustifolia fractions (F1-F6) exhibited some degree of 
antimicrobial activity against the cariogenic bacteria, S. mutans (Table 3.2, Figure 3.5). The 
fractions were tested for activity against two S. mutans strains, ATCC 10923 (1) and the 
clinical strain, SM1 (2).  Microtitre plates in Figure 3.5 shows the antimicrobial activity of 
different fractions after incubation at 37 °C and adding INT dye. 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Microtitre plates showing antimicrobial activity tests of fractions (F1-F6). 
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There was no growth observed in the positive control which had chlorhexidine. The negative 
control with water and the solvent (DMSO) had growth. The lowest minimum inhibitory 
concentration (MIC) recorded was from fraction 5 with a value of 0.39 mg/ml and with a 
minimum bactericidal concentration value of 0.78 mg/ml. These results are in congruent with 
what was observed from bioautography analysis where F5 had a bigger zone of inhibition. 
The MICs of D. viscosa var. angustifolia fractions ranged between 0.39-6.25 mg/ml. 
 
Table 3.2 also shows a summary of the antimicrobial activity tests done for screening 
fractions for their efficacy against S. mutans. The concept of total activity is also introduced 
in the table. When screening fractions for their antimicrobial effect, total activity is used to 
determine any loss or gain of activity during fractionation of the crude extract. Total activity 
takes into consideration the MIC of the fraction and its quantity.  
               
        
   
 
Table 3.2 Summary of the antibacterial activity of D. viscosa var. angustifolia crude extract 
and fractions against S. mutans 
 
Test   Crude F1 F2 F3 F4 F5 F6 
Quantity(mg) 6800 920 840 1950 60 780 1550 
MIC 
mg/ml 
1 0.78 12.5 6.25 6.25 12.5 0.39 1.56 
2 0.78 12.5    12.5 6.25 6.25 0.39 1.56 
Total activity - 73.6 89.6 312 6.4 2000 993.6 
MBC  
mg/ml 
1 1.56 12.5 12.5 6.25 12.5 0.78 3.125 
2 1.56 12.5 12.5 12.5 12.5 0.78 3.125 
Bioautogram 
  Rf values 
Four 
bands 
of 
activity 
One 
faint 
band 
Rf: 
0.96 
No 
activity 
One 
faint 
band 
Rf: 
0.47 
No 
activity 
Two 
clear 
bands 
Rf: 0.19 
and 0.17 
One 
faint 
band 
Rf: 0.14 
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Fraction 5 had the highest total activity value of 2000 followed by fraction 6 at 993.6. 
Fraction 4 had the lowest total activity value of 6.4. The minimum bactericidal concentration 
(MBC) values of the fractions ranged from 0.78-12.5 mg/ml. Fraction 5 exhibited the lowest 
MBC value of 0.78 mg/ml which had improved compared to the crude extract. 
 
3.6 Effect of D. viscosa var. angustifolia crude extract and fractions on biofilm 
formation by S. mutans (Preliminary screening). 
 
Depending on the MBC values, three subinhibitory concentrations per fraction were selected 
and used for the assays as shown in Table 3.3. Bacterial counts in the biofilms were recorded 
after 6 and 24 hours. Percentage reduction in bacterial counts was calculated using the 
control counts. Only S. mutans strain ATCC 10923 was used for screening and one repeat 
was carried out per fraction. Table 3.4 shows the results of the effect of fractions on biofilm 
formation by S. mutans. 
 
Table 3.3: Outline of the concentrations used for biofilm and acid production assays 
 
Concentrations   
used (mg/ml) 3.125 1.56 0.78 0.39 0.2 0.1 0.05 
Crude   x x x   
F1 x x x     
F2 x x x     
F3   x x x   
F4 x x x     
F5     x x x 
F6   x x x   
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Table 3.4: Effect of subinhibitory concentrations of D. viscosa var. angustifolia fractions on 
biofilm formation by S. mutans  
 
Dodonaea viscosa var. angustifolia fractions significantly reduced the attachment of S. 
mutans cells to the glass slides. The biofilm counts of S. mutans from the control slides were 
higher than those exposed to the fractions for all the exposure time intervals. There was an 
increase in log CFU/ml of S. mutans after 24 hours in all the assays but the control biofilm 
counts were still significantly higher compared to those exposed to the DVA fractions.  
 
 
 
Fractions 
                          Growth of S. mutans in biofilm (CFU/ml): Strain ATCC 10923 
    Plant  
 (mg/ml) 
                                   6 hours                                   24 hours 
  Control    Plant %Reduction  Control   Plant %Reduction 
 
  Crude  
0.78 2.2x10
5 
3.9 x 10
4 
82.3 2.2x10
7 
2.1 x 10
6 
90.5 
0.39 2.2x10
5 
6.2 x 10
4 
71.8 2.2x10
7 
4.1 x 10
6 81.4 
0.2 2.2x10
5 
9.6 x 10
4 
56.4 2.2x10
7 
8.7 x 10
6 60.5 
 
Fraction 1 
3.125 5.5x10
5 
1.3 x 10
5   
 76.4 4.8x10
7 
7.2 x 10
6 85.0 
1.56 5.5x10
5 
2.4 x 10
5
 56.4 4.8x10
7
 9.7 x 10
6 79.8 
0.78 5.5x10
5 
3.7 x 10
5
 32.7 4.8x10
7
 1.8 x 10
7
 62.5 
 
Fraction 2 
3.125 5.5x10
5 
2.1 x 10
5
 61.8 4.8x10
7
 9.3 x 10
6 80.6 
1.56 5.5x10
5 
3.2 x 10
5
 41.8 4.8x10
7
 1.6 x 10
7 66.7 
0.78 5.5x10
5 
3.9 x 10
5
 29.1 4.8x10
7
 2.9 x 10
7 35.6 
 
Fraction 3 
0.78 5.5x10
5 
9.1 x 10
4 83.5 4.8x10
7
 6.5 x 10
6 86.5 
0.39 5.5x10
5
 2.8 x 10
5
 67.3 4.8x10
7
 8.3 x 10
6
 82.7 
0.20 5.5x10
5
 3.1 x 10
5
 43.6 4.8x10
7
 1.5 x 10
7
 68.8 
 
Fraction 4 
3.125 1.2x10
5 
4.8 x 10
4
 60.0 5.7x10
7 
1.2 x 10
7 78.9 
1.56 1.2x10
5
 5.3 x 10
4
 55.8 5.7x10
7
 2.4 x 10
7 57.9 
0.78 1.2x10
5
 6.9 x 10
4 42.5 5.7x10
7
 3.4 x 10
7 40.4 
 
Fraction 5 
0.20 1.2x10
5
 1.5 x 10
4 87.5 5.7x10
7
 3.8 x 10
6 93.3 
0.10 1.2x10
5
 2.2 x 10
4 81.7 5.7x10
7
 4.7 x 10
6 91.7 
0.05 1.2x10
5
 3.9 x 10
4 67.5 5.7x10
7
 6.2 x 10
6 89.1 
 
Fraction 6 
0.78 1.2x10
5
 2.5 x 10
4 79.2 5.7x10
7
 5.8 x 10
6 89.8 
0.39 1.2x10
5
 4.6 x 10
4
 61.7 5.7x10
7
 8.3 x 10
6
 85.4 
0.20 1.2x10
5
 6.3 x 10
4
 47.5 5.7x10
7
 9.2 x 10
6
 83.9 
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Fraction 5 had the highest anticariogenic activity as indicated by its high biofilm inhibition 
effect of 93.3 % after 24 hours with the lowest subinhibitory concentration of 0.2 mg/ml. The 
intermediate subinhibitory concentration of 0.1 mg/ml from fraction 5 also exhibited greater 
biofilm activity of 91.7% after 24 hours compared to all the other fractions. The inhibitory 
effect was also higher than the crude extract whose subinhibitory concentration value of 0.78 
mg/ml had 90.5 % inhibition effect after 24 hours. The biofilm inhibition effect of the plant  
extracts was shown to be concentration depended with higher concentrations having a more 
pronounced inhibitory effect. The pronounced inhibitory effect from fraction 5 indicated that 
it contained an active compound in more concentrated form than in the crude extract. 
 
 
3.7 Effect of D. viscosa var. angustifolia crude extract and fractions on acid production 
by S. mutans (Preliminary screening). 
 
Streptococcus mutans cells were incubated in the presence of subinhibitory concentrations of 
D. viscosa var. angustifolia fractions. The same three subinhibitory concentrations used for 
the biofilm inhibition effect were used for the acid production assays (Table 3.3). 
Streptococcus mutans strain ATCC 10923 was used for acid production assays. The pH was 
measured at beginning of incubation, after 8 hours and then every 2 hours up to 14 hours. 
The results are presented in Table 3.5. Bacterial counts were also carried out from all the 
assays at 0, 8 and 10 hours. Bacterial counts were done to prove that any differences in pH 
observed were due to the inhibitory effect on acid production by fractions on S. mutans not 
due to the differences in bacterial counts. The results are shown in Table 3.6.
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Table 3.5 Effect of subinhibitory concentrations of D. viscosa var. angustifolia crude extract and fractions on acid production by 
S. mutans 
Plant 
 DVA 
(mg/ml) 
                                     Acid production by S. mutans: Strain 10923 (pH) pH Difference 
after 14 hours 0 hours 8 hours 10 hours 12 hours 14 hours 
Control Plant Control Plant Control Plant Control Plant Control Plant Control Plant 
 
Crude 
0.78 7.47 7.47 6.02 7.21 5.81 6.33 4.84 5.98 4.56 5.45 2.91 2.02 
0.39 7.47 7.47 6.02 6.83 5.81 6.08 4.84 5.61 4.56 5.16 2.91 2.31 
0.20 7.47 7.47 6.02 6.75 5.81 5.96 4.84 5.28 4.56 4.93 2.91 2.54 
 
Fraction1 
3.125 7.49 7.49 6.22 7.04 5.76 6.68 5.28 6.14 4.81 5.48 2.68 2.01 
1.56 7.49 7.49 6.22 6.93 5.76 6.38 5.28 5.63 4.81 5.11 2.68 2.38 
0.78 7.49 7.49 6.22 6.71 5.76 6.02 5.28 5.52 4.81 4.97 2.68 2.52 
 
Fraction2  
3.125 7.49 7.49 6.22 7.02 5.76 6.74 5.28 5.98 4.81 5.43 2.68 2.06 
1.56 7.49 7.49 6.22 6.83 5.76 6.33 5.28 5.61 4.81 5.12 2.68 2.37 
0.78 7.49 7.49 6.22 6.47 5.76 6.08 5.28 5.36 4.81 4.80 2.68 2.69 
 
Fraction3  
0.78 7.47 7.47 6.02 6.96 5.81 6.31 4.84 6.06 4.56 5.62 2.91 1.85 
0.39 7.47 7.47 6.02 6.89 5.81 6.04 4.84 5.82 4.56 5.13 2.91 2.34 
0.20 7.47 7.47 6.02 6.86 5.81 5.73 4.84 5.41 4.56 4.94 2.91 2.53 
 
Fraction4  
3.125 7.48 7.48 6.14 6.62 5.88 6.28 5.42 5.91 5.04 5.38 2.44 2.10 
1.56 7.48 7.48 6.14 6.54 5.88 6.12 5.42 5.67 5.04 5.14 2.44 2.34 
0.78 7.48 7.48 6.14 6.48 5.88 5.48 5.42 5.28 5.04 4.96 2.44 2.52 
 
Fraction5 
0.20 7.47 7.47 6.02 7.38 5.81 6.81 4.84 6.26 4.56 5.96 2.91 1.51 
0.10 7.47 7.47 6.02 6.92 5.81 6.42 4.84 6.02 4.56 5.73 2.91 1.74 
0.05 7.47 7.47 6.02 6.87 5.81 6.11 4.84 5.84 4.56 5.44 2.91 2.03 
 
Fraction6  
0.78 7.47 7.47 6.02 6.76 5.81 6.54 4.84 6.07 4.56 5.81 2.91 1.66 
0.39 7.47 7.47 6.02 6.69 5.81 6.36 4.84 5.84 4.56 5.32 2.91 2.15 
0.20 7.47 7.47 6.02 6.63 5.81 5.87 4.84 5.53 4.56 5.11 2.91 2.36 
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All the fractions inhibited acid production of S. mutans. After 10 hours, control cultures had 
attained the critical pH of 5.5 which is cariogenic. Cultures with plant extract only reached 
this critical pH after 14 hours. The results were simplified by calculating the difference in pH 
at 0 and 14 hours as shown in Table 3.5. 
 
A lower difference in the pH recorded at 0 hours and 14 hours indicated that acid production 
by S. mutans was more highly inhibited. The highest subinhibitory concentration of 0.2 
mg/ml from fraction 5 had the least change in pH after 14 hours with a calculated value of 
1.51. This value was evidently lower when compared to the control which had a pH 
difference of 2.91 after 14 hours. Among the six fractions, the highest change in pH was 
observed from the lowest subinhibitory concentration of fraction 2 (0.78mg/ml) which had a 
pH change of 2.69. However, the inhibitory effect was still evident when compared to the 
control.  Table 3.6 shows the bacterial counts at 0, 8 and 10 hours. Streptococcus mutans 
counts in the exposed cultures and controls increased with time. From observation, bacterial 
counts between the controls and test cultures were not very different. This indicated that the 
inhibitory effect in acid production observed between controls and fractions was not due to 
differences in bacterial counts. 
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Table 3.6: Streptococcus mutans counts (CFU/ml) in the presence and absence of 
subinhibitory concentrations of D. viscosa var. angustifolia crude extract and fractions. 
 
 
 
 
 
 
Fractions Growth of S. mutans (CFU/ml) in acid production assay : Strain ATCC 10923 
DVA           
(mg/ml) 
0 hours 8 hours 10 hours 
Control    Plant Control Plant Control Plant 
Crude 
0.78 9.3x10
5 
8.8x10
5 
1.9x10
7
 6.1x10
6 
7.4x10
7 
9.4x10
6 
0.39 9.7x10
5 
7.9x10
5 
1.9x10
7
 7.4x10
6 
7.4x10
7
 1.5x10
7 
0.2 8.4x10
5 
8.6x10
5 
1.9x10
7
 8.2x10
6 
7.4x10
7
 3.4x10
7 
Fraction 1 
3.125 8.3x10
5 
7.6x10
5 
1.7x10
7 
5.4x10
6 
6.9x10
7 
2.3x10
7 
1.56 7.8x10
5 
8.1x10
5 
1.7x10
7
 6.3x10
6 
6.9x10
7
 2.9x10
7 
0.78 8.6x10
5 
7.3x10
5 
1.7x10
7
 7.6x10
6 
6.9x10
7
 3.4x10
7 
Fraction 2 
3.125 8.3x10
5 
7.6x10
5 
1.7x10
7
 6.1x10
6 
6.9x10
7
 2.1x10
7 
1.56 7.8x10
5 
8.1x10
5 
1.7x10
7
 7.2x10
6 
6.9x10
7
 2.4x10
7 
0.78 8.6x10
5 
7.3x10
5 
1.7x10
7
 7.9x10
6
 6.9x10
7
 3.6x10
7 
Fraction 3 
0.78 9.3x10
5 
8.8x10
5 
1.9x10
7 
5.7x10
6 
7.4x10
7 
9.3x10
6 
0.39 9.7x10
5 
7.9x10
5 
1.9x10
7
 5.3x10
6 
7.4x10
7
 2.6x10
7 
0.20 8.4x10
5 
8.6x10
5 
1.9x10
7
 6.9x10
6 
7.4x10
7
 3.1x10
7 
Fraction 4 
3.125 1.3x10
6 
1.6x10
6 
2.5x10
7 
7.6x10
6 
7.8x10
7 
1.7x10
7 
1.56 1.6x10
6 
1.9x10
6 
2.5x10
7
 8.8x10
6 
7.8x10
7
 2.8x10
7 
0.78 1.1x10
6 
1.3x10
6 
2.5x10
7
 8.1x10
6 
7.8x10
7
 3.4x10
7 
Fraction 5 
0.20 9.3x10
5 
8.8x10
5 
1.9x10
7
 5.7x10
6 
7.4x10
7 
8.1x10
6 
0.10 9.7x10
5 
7.9x10
5 
1.9x10
7
 6.5x10
6 
7.4x10
7
 1.8x10
7 
0.05 8.4x10
5 
8.6x10
5 
1.9x10
7
 7.7x10
6 
7.4x10
7
 2.7x10
7 
Fraction 6 
0.78 9.3x10
5 
8.8x10
5 
1.9x10
7
 7.1x10
6 
7.4x10
7
 2.9x10
7 
0.39 9.7x10
5 
7.9x10
5 
1.9x10
7
 8.5x10
6
 7.4x10
7
 2.3x10
7
 
0.20 8.4x10
5 
8.6x10
5 
1.9x10
7
 7.8x10
6
 7.4x10
7
 3.7x10
7
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3.8  Purification of fraction 5 
 
3.8.1 Liquid chromatography purification 
 
Screening of the six fractions for anticariogenic potential showed that fraction 5 (F5) was the 
most effective. Fraction 5 was further purified using liquid chromatography which resulted in 
two subfractions, subfraction 5.1 and 5.2. Figure 3.6 shows the column detection peaks 
obtained from running the sample on the liquid chromatography machine at 254 nm. 
Subfractions with two clean peaks were collected and named as subfraction 5.1 and 5.2. A 
total of 120 mg and 76 mg of extract were collected for subfraction 5.1 and 5.2 respectively. 
A solvent gradient ratio of hexane and ethyl acetate was used for elution. 
 Sample name Fraction 5 User name  Tham 
 Solvent A n-Hexane Solvent B  Ethyl acetate 
 Flow rate(mL/min) 8.0 Run unit  Min 
 Rack type FS-18mm Fraction size(mL)  10.00 
 Detection(nm) 254 Monitor(nm)  280 
 Column  Flash Column 80g   
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Fraction 5 liquid chromatography profile for elution with a solvent gradient ratio 
of hexane and ethyl acetate.
Subfraction 5.1 
Subfraction 5.2 
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3.9 Determination of antimicrobial activity of subfraction 5.1 and subfraction 5.2  
Both D. viscosa var. angustifolia subfractions 5.1 and 5.2 exhibited antimicrobial activity 
against both S. mutans strains. The MIC and MBC results for the crude extract, subfraction 
5.1 and 5.2 on both S. mutans strains are presented in Table 3.7. All the assays were done in 
triplicate for both strains.  
 
Table 3.7: Minimum inhibitory concentrations and minimum bactericidal concentrations of 
D. viscosa var. angustifolia crude extract and subfractions 
 
The crude extract MBCs ranged from 1.56-3.125 mg/ml. The lowest MBC result recorded 
was observed from subfraction 5.1 at 0.1 mg/ml with S. mutans strain ATCC 10923. 
Subfraction 5.1 also had the lowest MIC recorded of 0.05 mg/ml indicating its significant 
antimicrobial potential against cariogenic bacteria, S. mutans (Table 3.7, Figure 3.7). 
Subfraction 5.2 did not exhibit significant difference in activity compared to the crude extract 
with the same MBC results which ranged from 1.56-3.125 mg/ml. Acetone was used to 
dissolve the extracts and did not have any noteworthy effect on the growth of bacteria. Figure 
3.7 shows the microtitre plates with the assays after incubating with INT dye. 
 
Cultures 
 
Repeats 
Crude Methanol 
Extract 
Sub-fraction 5.1 Sub-fraction 5.2 
   MIC 
(mg/ml) 
  MBC 
(mg/ml) 
   MIC 
(mg/ml) 
   MBC 
(mg/ml) 
   MIC 
(mg/ml) 
  MBC 
(mg/ml) 
      S. mutans 
ATCC 10923 
1 0.78 1.56 0.05 0.1 0.78 1.56 
2 0.78 1.56 0.05 0.1 1.56 3.125 
3 0.78 3.125 0.01 0.1 1.56 3.125 
Median  0.78 1.56 0.05 0.1 1.56 3.125 
S. mutans 
SM1 
1 0.78 1.56 0.1 0.2 0.78 1.56 
2 0.78 1.56 0.1 0.39 1.56 3.125 
3 0.78 1.56 0.1 0.39 1.56 3.125 
Median  0.78 1.56 0.1 0.39 1.56 3.125 
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Figure 3.7: Microtitre plates showing the antimicrobial activity tests of D. viscosa var. 
angustifolia crude extract and subfractions after incubation with INT dye. 
 
Subfraction 5.1 was the most active of the two subfractions with a higher total activity value 
of 1200 (120mg/0.1) compared to that of subfraction 5.2 which had a total activity value of 
48.7 (76mg/1.56) as recorded in Table 3.7. Subfraction 5.1 was chosen for further 
Subfraction 5.1 
exhibited the highest 
antibacterial activity 
on both S.mutans 
strains with an average 
MIC of 0.1 mg/ml 
Positive control (CHX): 
no growth 
Solvent (Acetone): 
growth 
Negative control (dH2O 
with culture): growth 
 
C- Crude extract 
5.1- Subfraction 5.1 
5.2- Subfraction 5.2 
S
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a
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 1
0
9
2
3
 
S
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a
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M
1
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anticariogenic activity assays together with the crude extract for comparison as shown in 
Table 3.8. 
 
Table 3.8: Outline of the concentrations used for further biofilm and acid production assays. 
Concentrations used 
(mg/ml) 
Crude extract Subfraction 5.1 
0.78 x  
0.39 x  
0.2 x  
0.1   
0.05  x 
0.025  x 
0.0125  x 
 
Biofilm formation and acid production assays were carried out using both S. mutans strains, 
ATCC 10923 and SM1. The experiments were repeated three times producing six results 
which were statistically analyzed. 
 
3.9.1 Effect of crude methanol extract and subfraction 5.1 on Streptococcus mutans 
biofilm formation  
 
Table 3.9, Figure 3.8 and Figure 3.9 show the results of the effect of D. viscosa var. 
angustifolia crude methanol extract and subfraction 5.1 on biofilm formation by S. mutans. 
The effect of D. viscosa var. angustifolia on S. mutans biofilm formation was investigated 
using three subinhibitory concentrations from the crude extract and subfraction 5.1. The 
results were recorded after 6 and 24 hours of exposure. The assays were done in triplicate for 
each of the two strains.  Means and standard deviations were calculated.  
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Both the crude extract and subfraction 5.1 exhibited significant biofilm inhibition after 6 and 
24 hours of incubation. The biofilm counts increased with time for all the assays but the 
slides exposed to D. viscosa var. angustifolia still had lower counts compared to the control 
slides. The biofilm reduction effect was shown to be concentration dependent for all the 
exposure assays. The highest subinhibitory concentration of 0.78 mg/ml from the crude 
extract reduced biofilm bacterial count by a difference of  0.94 and 1.19 log CFU counts in 
comparison with the control after 6 and 24 hours respectively. For subfraction 5.1, the 
highest subinhibitory concentration of 0.05 mg/ml reduced biofilm formation by 1.18 and 2 
log CFU counts in comparison with the control after 6 and 24 hours respectively.  
 
The lower subinhibitory test concentrations from subfraction 5.1 (0.05 mg/ml – 0.0125 
mg/ml) had a better biofilm inhibitory effect compared to the corresponding crude extract 
subinhibitory concentrations (0.78 mg/ml – 0.2 mg/ml).  This indicated that the purified 
subfraction had more anticariogenic activity compared to the crude extract. The percentage 
reduction in biofilm bacterial counts was also calculated for both the crude extract and 
subfraction using controls. The results are presented in Table 3.10.   
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Table 3.9 Effect of subinhibitory concentrations of D. viscosa var. angustifolia crude extract and subfraction 5.1 on S. mutans biofilm  
 
 
 
Cultures 
 
 
 
Repeats 
                                        Growth of S. mutans in biofilm (CFU/ml): Crude extract 
                                            6 hours                                      24 hours 
  0.78 mg/ml  0.39 mg/ml   0.2 mg/ml   0.78 mg/ml  0.39 mg/ml   0.2 mg/ml 
Control  Plant Control  Plant Control  Plant Control  Plant Control   Plant Control  Plant 
S. mutans 
ATCC 
10923 
1 2.2x10
5 
3.9x10
4 
2.2x10
5 
6.2x10
4 
2.2x10
5 
9.6x10
4 
2.2x10
7 
1.3x10
6 
2.2x10
7 
3.6x10
6 
2.2x10
7 
8.7x10
6 
2 3.6x10
5
 2.4x10
4 
3.6x10
5
 7.8x10
4 
3.6x10
5
 2.3x10
5 
1.9x10
7 
2.4x10
6 
1.9x10
7 
2.8x10
6 
1.9x10
7 
6.7x10
6 
3 1.7x10
5 
2.9x10
4 
1.7x10
5 
5.1x10
4 
1.7x10
5 
8.9x10
4 
2.8x10
7 
1.8x10
6 
2.8x10
7 
2.4x10
6 
2.8x10
7 
6.4x10
6 
 Mean 2.5x10
5 
3.1x10
4 
2.5x10
5
 6.4x10
4 
2.5x10
5
 1.4x10
5 
2.3x10
7 
1.8x10
5 
2.3x10
7
 2.9x10
6 
2.3x10
7
 7.2x10
6 
S. mutans 
SM1 
1 8.4x10
6 
8.9x10
5 
8.4x10
6 
1.1x10
6
 8.4x10
6 
3.2x10
6
 3.1x10
8 
2.6x10
7 
3.1x10
8 
4.8x10
7 
3.1x10
8 
7.9x10
7 
2 6.6x10
6 
7.8x10
5 
6.6x10
6 
9.4x10
5 
6.6x10
6 
2.9x10
6 
2.6x10
8 
1.1x10
7 
2.6x10
8 
5.4x10
7 
2.6x10
8 
7.1x10
7 
3 7.4x10
6 
9.3x10
5 
7.4x10
6 
9.8x10
5 
7.4x10
6 
2.5x10
6 
1.9x10
8 
1.8x10
7 
1.9x10
8 
3.2x10
7 
1.9x10
8 
6.7x10
7 
 Mean 7.5x10
6 
8.7x10
5 
7.5x10
6
 1.0x10
6 
7.5x10
6
 2.9x10
6 
2.5x10
8 
1.8x10
7 
2.5x10
8
 4.5x10
7
 2.5x10
8
 7.2x10
7 
Pool mean  3.9x10
6 
4.5x10
5 
3.9x10
6 
5.3x10
5 
3.9x10
6 
1.5x10
6 
1.4x10
8 
9.1x10
6 
1.4x10
8 
2.4x10
7 
1.4x10
8 
3.9x10
7 
±SD  3646.2 420421 3646.2 116210 3646.2 137991 120338 932423 120338  21878 120338 327319 
 
                                              
 
 
Cultures 
           
 
 
Repeats 
                                          Growth of S. mutans in biofilm (CFU/ml): Subfraction 5.1 
                                            6 hours                                      24 hours 
  0.05 mg/ml  0.025 mg/ml   0.0125 mg/ml   0.05 mg/ml  0.025 mg/ml   0.0125 mg/ml 
Control Plant Control Plant Control Plant Control Plant Control Plant Control   Plant 
S. mutans 
ATCC 
10923 
1 1.9x10
5 
1.6x10
4 
1.9x10
5
 5.6x10
4
 1.9x10
5
 8.4x10
4
 4.1x10
7 
3.8x10
5 
4.1x10
7 
7.4x10
5
 4.1x10
7 
5.2x10
6
 
2 3.4x10
5
 1.9x10
4
 3.4x10
5
 4.3x10
4
 3.4x10
5
 9.8x10
4
 2.8x10
7
 4.2x10
5
 2.8x10
7
 8.9x10
5
 2.8x10
7
 4.8x10
6
 
3 2.4x10
5
 1.1x10
4
 2.4x10
5
 4.9x10
4
 2.4x10
5
 9.2x10
4
 3.4x10
7
 3.5x10
5
 3.4x10
7
 8.3x10
5
 3.4x10
7
 5.6x10
6
 
 Mean 2.6x10
5 
1.5x10
4 
2.6x10
5
 6.6x10
4 
2.6x10
5
 9.1x10
4 
3.4x10
7 
3.8x10
5 
3.4x10
7
 8.2x10
5 
3.4x10
7
 5.2x10
6 
S. mutans 
 SM1 
1 3.9x10
6 
2.1x10
5 
3.9x10
6 
3.7x10
5 
3.9x10
6 
6.4x10
5
 3.6x10
8
 2.3x10
6 
3.6x10
8
 6.4x10
6 
3.6x10
8
 4.5x10
7
 
2 1.7x10
6
 1.4x10
5
 1.7x10
6
 1.9x10
5
 1.7x10
6
 4.8x10
5
 2.7x10
8
 3.1x10
6
 2.7x10
8
 5.6x10
6
 2.7x10
8
 3.9x10
7
 
3 2.9x10
6
 1.8x10
5
 2.9x10
6
 2.5x10
5
 2.9x10
6
 5.6x10
5
 2.1x10
8
 3.4x10
6
 2.1x10
8
 5.3x10
6
 2.1x10
8
 2.6x10
7
 
 Mean 2.8x10
6 
1.8x10
5 
2.8x10
6
 2.7x10
5 
2.8x10
6
 5.6x10
5 
2.8x10
8 
2.9x10
6 
2.8x10
8
 5.8x10
6 
2.8x10
8
 3.7x10
7 
Pool mean  1.5x10
6 
9.8x10
4 
1.5x10
6
 1.7x10
5 
1.5x10
6
 3.3x10
5 
1.6x10
8 
1.6x10
6 
1.6x10
8
 3.3x10
6 
1.6x10
8
 2.1x10
7 
±SD  143742  83208 143742 122423 143742 238876  1303.4 131674 1303.4 249540 1303.4 167043 
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Figure 3.8: Effect of subinhibitory concentrations of crude 
extract on Streptococcus mutans biofilm formation (log 
CFU/ml) after 6 and 24 hour of exposure. *, **: Comparison 
between bacterial counts of controls and treated S. mutans 
cultures after 6 and 24 hours using the Wilcoxon rank-sum 
test (Mann-Whitney). 
 
Figure 3.9: Effect of subinhibitory concentrations of 
subfraction 5.1 on Streptococcus mutans biofilm formation 
(log CFU/ml) after 6 and 24 hours of exposure. *, **: 
Comparison between bacterial counts of controls and treated 
S. mutans cultures after 6 and 24 hours using the Wilcoxon 
rank-sum test (Mann-Whitney). 
 
 
*, **: p < 0.01 *, **: p < 0.01 
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Table 3.10 Percentage reduction in biofilm formation after exposure to subinhibitory concentrations of D. viscosa var. angustifolia 
crude extract and subfraction 5.1 
 
 
Cultures 
 
Repeats 
                                                 % Reduction in biofilm formation: Crude extract 
                          Crude (mg/ml): 6 hours                             Crude (mg/ml): 24 hours  
         0.78          0.39           0.2          0.78          0.39           0.2 
S. mutans 
ATCC               
10923 
1 82.3 71.8 56.4 94.1 83.6 60.5 
2 93.3 78.3 36.1 87.4 85.3 64.7 
3 82.9 70.0 47.6 93.6 91.4 77.1 
 Mean 86.2 73.4 46.7 91.7 86.8 67.4 
 
S. mutans 
SM1 
1 89.4 86.9 61.9 91.6 84.5 74.5 
2 88.2 85.8 56.1 95.7 79.2 72.3 
3 87.4 86.7 66.2 90.6 83.2 64.7 
 Mean 88.3 86.5 61.4 92.6 82.3 70.5 
 Combined Mean 87.3 79.9 54.1 92.2 84.5 68.9 
 Combined ±SD 4.643544 7.026478 9.855413 2.701029 3.624761 5.99963 
Wilcoxon-Rank sum test P < 0.01 P < 0.01 
 
Cultures 
 
Repeats 
% Reduction in biofilm formation: Sub-fraction 5.1 
Sub-fraction 5.1 (mg/ml): 6 hours Sub-fraction 5.1 (mg/ml): 24 hours 
0.05 0.025  0.0125 0.05  0.025 0.0125  
S. mutans 
ATCC 
10923 
1 92.7 74.5 61.8 99.1 98.2 87.3 
2 94.4 87.3 71.2 98.5 96.8 82.9 
3 95.4 79.6 61.6 98.9 97.6 83.5 
 Mean 94.2 80.5 64.9 98.8 97.5 84.6 
S. mutans 
SM1 
1 94.6 90.5 83.6 99.4 98.2 87.5 
2 91.8 88.8 71.8 98.9 97.9 85.5 
3 93.7 91.4 80.7 98.4 97.4 87.6 
 Mean 93.4 90.2 78.7 98.9 97.8 86.9 
 Combined Mean 93.8 85.4 71.8 98.9 97.7 85.7 
 Combined ±SD 1.421756 7.404372 9.68012 0.339935 0.489898 1.920431 
Wilcoxon-Rank sum test P < 0.01 P < 0.01 
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When the percentage reduction in the biofilm was compared, similar significant reduction 
was noted with crude extract at 6 and 24 hours (p<0.01) and with subfraction 5.1 (p<0.01) as 
shown in Table 3.10. The subinhibitory concentration of 0.78 mg/ml from the crude extract 
reduced biofilm formation by an average of 87.3 % after 6 hours of incubation. This 
reduction was less significant when compared to the effect of subfraction 5.1 which reduced 
biofilm formation by an average of 93.8 % at 0.05 mg/ml after 6 hours of incubation. The 
same effect was observed after 24 hours of exposure where the crude extract reduced biofilm 
formation by an average of 92.2 % and subfraction 5.1 reduced biofilm formation by an 
average of 98.9 %. Overall the subfraction performed better than the crude extract producing 
greater percentage reduction of biofilm at much lower concentrations. 
    
3.9.2 Effect of crude methanol extract and subfraction 5.1 on acid production by S. 
mutans  
 
Results of the effect of crude extract and subfraction 5.1 on acid production by S. mutans are 
shown in Table 3.11 and 3.12 respectively. Three subsequent subinhibitory concentrations 
were used in the assays for each S. mutans strain. Tests were done in triplicate. Means and 
standard deviations of the pH values were calculated for each of the S. mutans strains. These 
are represented in Figure 3.10 for the crude extract and Figure 3.11 for subfraction 5.1. The 
pH was first measured at 0 hours for all the assays and then every 2 hours following an 8 
hour incubation period up to 14 hours. There was a gradual drop in pH with time for both the 
controls and assays indicating bacterial growth (Table 3.11 and Table 3.12). It was important 
though to prove that the difference in pH between the control and treated assays was not due 
to significant differences in the number of S. mutans cells hence bacterial counts were done 
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at 0, 8, and 10 hours. Streptococcus mutans counts are presented in Table 3.13, Figure 3.10 
and Figure 3.11.
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Table 3.11 Effect of subinhibitory concentrations of crude extract on acid production by S. mutans 
 
 
 
 
 Cultures 
    Plant 
 (mg/ml) 
                     Effect of crude on acid production by S. mutans (pH) pH difference 
after 14 hours Repeats        0 hours        8 hours           10 hours        12 hours       14 hours 
 
S. mutans 
ATCC 
10923 
 
0.78 
 Control Plant Control Plant Control Plant Control Plant Control Plant Control Crude 
1      7.48 6.75 7.22 6.12 6.87 5.61 6.64 5.27 6.48 2.22 1 
2      7.47 6.68 7.26 6.09 6.83 5.58 6.61 5.31 6.45 2.18 1.02 
3      7.48 6.78 7.24 6.05  6.82 5.67 6.59 5.25 6.51 2.24 0.97 
Mean      7.48 6.74 7.24 6.08 6.84 5.62 6.61 5.28 6.48 2.21 0.99 
 
0.39 
1      7.47 6.75 7.11 6.12 6.69 5.61 6.38 5.27 6.23 2.22 1.24 
2      7.47 6.68 7.14 6.09 7.67 5.58 6.35 5.31 6.19 2.18 1.28 
3      7.48 6.78 7.09 6.05 6.71 5.67 6.37 5.25 6.20 2.24 1.28 
Mean      7.48 6.74 7.11 6.09 6.69 5.62 6.36 5.28 6.21 2.21 1.27 
 
 
0.2 
1      7.47 6.75 6.94 6.12 6.48 5.61 6.19 5.27 6.01 2.22 1.46 
2      7.48 6.68 6.92 6.09 6.53 5.58 6.23 5.31 5.98 2.18 1.50 
3      7.47 6.78 6.89 6.05 6.48 5.67 6.20 5.25 5.97 2.24 1.50 
Mean      7.47 6.74 6.91 6.09 6.50 5.62 6.21 5.28 5.99 2.21 1.49 
 
 
 
S. mutans 
SM1 
0.78 
1      7.48 6.87 7.19 6.23 6.82 5.72 6.58 5.24 6.41 2.25 1.07 
2      7.48 6.79 7.24 6.18 6.80 5.68 6.63 5.18 6.38 2.31 1.10 
3      7.48 6.84 7.16 6.12 6.77 5.76 6.60 5.12 6.43 2.37 1.05 
Mean      7.48 6.83 7.20 6.18 6.79 5.72 6.61 5.18 6.41 2.31 1.07 
 
0.39 
1      7.48 6.87 7.03 6.23 6.66 5.72 6.33 5.24 6.19 2.25 1.29 
2      7.48 6.79 7.08 6.18  6.63 5.68 6.29 5.18 6.14 2.31 1.34 
3      7.49 6.84 7.06 6.12 6.62 5.76 6.35 5.12 6.17 2.37 1.32 
Mean      7.48 6.83 7.06 6.18 6.64 5.72 6.32 5.18 6.16 2.31 1.32 
 
 
0.2 
1      7.48 6.87 6.93 6.23 6.45 5.72 6.14 5.24 5.90 2.25 1.58 
2      7.47 6.79 6.90 6.18 6.47 5.68 6.12 5.18 5.89 2.31 1.57 
3      7.49 6.84 6.88 6.12 6.51 5.76 6.17 5.12 5.87 2.37 1.62 
Mean      7.48 6.83 6.90 6.18 6.48 5.72 6.14 5.18 5.89 2.31 1.59 
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Table 3.12: Effect of subinhibitory concentrations of subfraction 5.1 on acid production by S. mutans 
  
 Cultures  Plant 
mg/ml 
                     Effect of sub-fraction 5.1 on acid production by S. mutans (pH)  pH difference 
after 14 hours Repeats        0 hours        8 hours           10 hours        12 hours       14 hours 
 
S. mutans 
ATCC 
10923 
 
 0.05 
 Control   Plant Control Plant Control Plant Control Plant Control Plant Control 5.1 
1      7.48 6.75 7.38 6.12 7.31 5.61 7.18 5.27 7.11 2.22 0.37 
2      7.49 6.68 7.35 6.09 7.27 5.58 7.14 5.31 7.05 2.18 0.44 
3      7.48 6.78 7.41 6.05 7.33 5.67 7.21 5.25 7.08 2.24 0.40 
Mean      7.48 6.74 7.38 6.08 7.30 5.62 7.18 5.28 7.08 2.21 0.40 
    
 0.025 
1      7.49 6.75 7.28 6.12 7.21 5.61 6.99 5.27 6.84 2.22 0.65 
2      7.48 6.68 7.25 6.09 7.18 5.58 7.03 5.31 6.91 2.18 0.57 
3      7.48 6.78 7.31 6.05 7.24 5.67 7.08 5.25 6.87 2.24 0.61 
Mean      7.48 6.74 7.28 6.09 7.21 5.62 7.03 5.28 6.87 2.21 0.61 
   
 
 0.013 
1      7.48 6.75 7.18 6.12 6.94 5.61 6.85 5.27 6.69 2.22 0.79 
2      7.48 6.68 7.13 6.09 6.87 5.58 6.79 5.31 6.64 2.18 0.84 
3      7.48 6.78 7.23 6.05 6.98 5.67 6.74 5.25 6.61 2.24 0.87 
Mean      7.48 6.74 7.18 6.09 6.93 5.62 6.79 5.28 6.65 2.21 0.83 
 
 
 
 
 
S. mutans 
SM1 
0.05 
1      7.48 6.87 7.31 6.23 7.25 5.72 7.18 5.24 7.07 2.25 0.41 
2      7.49 6.79 7.28 6.18 7.21 5.68 7.13 5.18 7.00 2.31 0.49 
3      7.48 6.84 7.34 6.12 7.27 5.76 7.15 5.12 7.02 2.37 0.46 
Mean      7.48 6.83 7.31 6.18 7.24 5.72 7.15 5.18 7.03 2.31 0.45 
    
 0.25 
1      7.49 6.87 7.25 6.23 7.14 5.72 7.08 5.24 6.91 2.25 0.58 
2      7.48 6.79 7.28 6.18 7.18 5.68 7.05 5.18 6.84 2.31 0.64 
3      7.49 6.84 7.23 6.12 7.10 5.76 6.98 5.12 6.81 2.37 0.68 
Mean      7.49 6.83 7.25 6.18 7.14 5.72 7.04 5.18 6.85 2.31 0.63 
   
   
0.013 
1      7.48 6.87 7.15 6.23 6.94 5.72 6.72 5.24 6.54 2.25 0.94 
2      7.48 6.79 7.11 6.18 6.87 5.68 6.69 5.18 6.49 2.31 0.99 
3      7.49 6.84 7.09 6.12 6.83 5.76 6.75 5.12 6.59 2.37 0.90 
Mean      7.48 6.83 7.12 6.18 6.88 5.72 6.72 5.18 6.54 2.31 0.94 
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Table 3.13: Streptococcus mutans counts (CFU/ml) in the presence and absence of subinhibitory concentrations of crude extract and 
subfraction 5.1. 
 
 
Cultures 
                        
 
Repeats 
                                              Growth of S. mutans in acid production bioassay (CFU/ml) 
                                                                                                 Crude extract 
                       0 hours                         8 hours                               10 hours 
  Control  0.78   0.39    0.2 Control  0.78   0.39    0.2 Control  0.78   0.39    0.2 
S. mutans 
ATCC 
10923 
1 4.2x10
4 
3.5x10
4 
3.4x10
4 
4.6x10
4 
6.5x10
6 
2.9x10
6 
3.8x10
6 
4.6x10
6 
9.4x10
6 
4.7x10
6 
5.9x10
6 
7.2x10
6 
2 3.7x10
4 
2.9x10
4 
3.9x10
4 
3.7x10
4 
6.1x10
6 
9.4x10
5
 4.1x10
6
 5.1x10
6 
1.3x10
7 
3.6x10
6 
6.3x10
6 
7.9x10
6 
3 5.8x10
4 
3.9x10
4 
4.1x10
4 
4.0x10
4 
5.8x10
6 
2.5x10
6 
3.4x10
6 
4.3x10
6 
2.1x10
7 
4.4x10
6 
6.6x10
6 
7.6x10
6 
 Mean 4.6x10
4 
3.4x10
4 
3.8x10
4 
4.1x10
4 
6.1x10
6 
2.1x10
6 
3.7x10
6
 4.7x10
6 
1.5x10
7 
4.2x10
6 
6.3x10
6 
7.5x10
6 
S. mutans 
SM 1 
1 6.3x10
5 
5.3x10
5 
5.7x10
5 
4.5x10
5 
3.2x10
7 
4.4x10
6 
6.1x10
6 
9.4x10
6 
8.1x10
7 
1.3x10
7 
4.1x10
7 
4.9x10
7 
2 5.1x10
5 
4.2x10
5 
4.9x10
5 
3.9x10
5 
2.9x10
7 
3.9x10
6 
7.8x10
6 
8.3x10
6 
9.9x10
7 
9.4x10
6 
3.8x10
7 
5.7x10
7 
3 5.9x10
5 
4.6x10
5 
5.2x10
5 
4.8x10
5 
3.5x10
7 
3.5x10
6 
7.1x10
6
 9.8x10
6 
8.6x10
7 
8.3x10
6 
4.9x10
7 
5.9x10
7 
 Mean 5.8x10
5 
4.7x10
5 
5.3x10
5 
4.4x10
5 
3.2x10
7 
3.9x10
6 
7.0x10
6 
9.2x10
6 
8.9x10
7 
1.0x10
7 
4.3x10
7 
5.5x10
7 
 ±SD 267908 220211 245454 201264 130503 111955 170236 230609 376422 333500 184948 239134 
 
 
 
 
Cultures 
                        
 
 
Repeats 
                                  Growth of S. mutans in acid production bioassay (CFU/ml) 
                                                                                       Sub-fraction 5.1 
                             0 hours                            8 hours                                10 hours 
Control  0.05   0.025  0.0125 Control  0.05   0.025 0.0125 Control  0.05   0.025 0.0125 
S. mutans 
ATCC 
10923 
1 2.7x10
4 
1.9x10
4 
3.3x10
4 
2.5x10
4 
5.5x10
6 
3.7x10
6 
4.1x10
6 
5.2x10
6 
1.4x10
7 
6.1x10
6 
6.9x10
6 
7.9x10
6 
2 2.2x10
4 
2.7x10
4 
2.9x10
4 
3.1x10
4 
5.1x10
6
 9.7x10
5
 4.6x10
6
 5.5x10
6
 2.4x10
7
 4.9x10
6
 6.6x10
6
 8.4x10
6
 
3 3.1x10
4 
2.4x10
4 
1.8x10
4 
2.0x10
4 
6.7x10
6
 3.5x10
6
 5.1x10
6
 4.8x10
6
 2.1x10
7
 5.8x10
6
 7.2x10
6
 8.2x10
6
 
 Mean 2.6x10
4 
2.3x10
4 
2.7x10
4 
2.5x10
4 
5.8x10
6 
2.4x10
6 
4.6x10
6
 5.1x10
6 
2.0x10
7 
5.6x10
6 
6.9x10
6 
8.2x10
6 
 
S. mutans 
SM 1 
1 4.3x10
5 
3.9x10
5 
3.1x10
5 
2.7x10
5 
2.7x10
7 
8.9x10
6 
9.4x10
6 
1.2x10
7 
5.1x10
7 
1.9x10
7 
4.9x10
7 
5.9x10
7 
2 3.7x10
5 
2.8x10
5 
3.8x10
5 
2.1x10
5 
3.9x10
7
 7.9x10
6
 8.8x10
6
 2.1x10
7
 7.3x10
7
 9.8x10
6
 4.4x10
7
 6.2x10
7
 
3 4.7x10
5 
4.1x10
5 
2.7x10
5 
1.8x10
5 
2.5x10
7
 9.1x10
6
 9.1x10
6
 1.8x10
7
 6.8x10
7
 2.2x10
7
 5.2x10
7
 6.7x10
7
 
 Mean 4.2x10
5 
3.6x10
5 
3.2x10
5 
2.2x10
5 
3.0x10
7 
8.6x10
6 
9.1x10
6 
1.7x10
7 
6.4x10
7 
1.7x10
7 
4.8x10
7 
6.3x10
7 
 ±SD 200467 173133 150215 100915 130469 310510 217230 648444 233339 676108 208483 266108 
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Table 3.14: Statistical analysis of the data obtained in the acid production assay 
 
  
Extract Test Comparison p values 
Crude 
pH 
Control to all concentrations 
(overall) 
0.0002 
Control to 0.78 mg/ml 0.04 
Control to 0.39 mg/ml 0.02 
Control to 0.2 mg/ml 0.03 
Bacterial counts 
Control to all concentrations 
(overall) 
0.013 
Control to 0.78 mg/ml 0.031 
Control to 0.39 mg/ml 0.25 
Control to 0.2 mg/ml 0.33 
Subfraction 
5.1 
pH 
Control to all concentrations 
(overall) 
<0.0001 
Control to 0.05 mg/ml 0.0002 
Control to 0.025 mg/ml 0.0001 
Control to 0.0125 mg/ml 0.0003 
Bacterial counts 
Control to all concentrations 
(overall) 
0.05 
Control to 0.05 mg/ml 0.10 
Control to 0.025 mg/ml 0.35 
Control to 0.0125 mg/ml 0.44 
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Figure 3.10: Streptococcus mutans bacterial counts (log CFU/ml) and mean pH values 
following exposure to subinhibitory concentrations of the crude extract  
The crude methanol extract effectively reduced acid production by S. mutans. Notable pH 
differences were observed after 8 hours of incubation. The average control pH dropped to 
5.23 after 14 hours which was lower than that of the exposed assays with the highest 
subinhibitory concentration (0.78 mg/ml) dropping to an average of 6.45 (Table 3.11 ). There 
was not much of a difference in bacterial counts between the controls and treated assays 
(Figure 3.10). Statistical analysis showed that the inhibitory effect of the overall 
concentrations was highly significant with a p value of 0.0002 as shown in Table 3.14. 
Statistical comparison between each of the three subinhibitory concentrations and controls 
also indicated that all the subinhibitory concentrations significantly reduced acid production 
by S. mutans. The slight difference in bacterial counts proved that the inhibitory effect was 
due to the plant and not differences in bacterial counts.  
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Figure 3.11: Streptococcus mutans bacterial counts (log CFU/ml) and mean pH values 
following exposure to subinhibitory concentrations of subfraction 5.1 
 
Subfraction 5.1 inhibited acid production more effectively at low concentrations compared to 
crude extract.  The drop in pH from the highest subinhibitory concentration of 0.05 mg/ml 
was 7.05 after 14 hours. That average pH was lower in comparison to the crude extract (0.78 
mg/ml) which had dropped to an average pH of 6.45 (Table 3.11).  There was no great 
difference (p=0.05) in bacterial counts between the controls and treated assays (Figure 3.11 
and Table 3.14). The inhibitory effect of the overall concentrations was highly significant 
when compared to the controls with a p value of < 0.0001 as shown in Table 3.14. All the 
three individual subinhibitory concentrations significantly reduced acid production by S. 
mutans (p<0.01). In addition, the inhibition was concentration dependent as shown in Figure 
3.11. 
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3.10 Gas Chromatography-Mass Spectrometry analysis of subfraction 5.1  
The initial step to identify subfraction 5.1 was through GC-MS analysis. Table 3.15 gives an 
outline of the main compounds that were identified by GC-MS. Figure 3.12 shows the GC-
MS chromatogram for subfraction 5.1. Each discrete chemical compound is represented by a 
peak. Most of the compounds detected were esters or derivatives of ester compounds. The 
highest peak was observed at a retention time (RT) of 6.574 which was detected as 2-
butoxyethanol which is a glycol ether derivative. This was followed by the peak at RT 
35.325 which was detected with 99% probability as 9- Octadecenoic acid (Z), methyl ester. 
Two more ester compounds were detected at RT 35.218 and 32.005 as 9, 12-Octadecadienoic 
acid (z,z)-methyl ester and Hexadecanoic acid, methyl ester respectively. The mass to charge 
ratio of the observed ionization peak 326.9 [M-3H] correlates with the molecular mass 
(330.28 g/mol) of the compound that was later identified as subfraction 5.1   
 
     Table 3.15: Main chemical compounds identified by GC-MS from the internal GC library      
     for subfraction 5.1 
 
                                       Main peaks subfraction 5.1 
Peak RT (mins) Area (%) Possible compounds 
1     6.574 6.40 
2-butoxyethanol 
Formic acid, 3,3- dimethylbut-2-yl ester 
2 22.720 0.77 
1tetradecamethylcycloheptasiloxane 
Pentasiloxane, dodecamethyl ester 
3 32.005 1.57 
Hexadecanoic acid, methyl ester 
Pentadecanoic acid, 14-methyl- methyl ester 
4 35.218 3.68 
9,12-Octadecadienoic acid (z,z)-, methyl ester 
10,13-Octadecadienoic acid , methyl ester 
8, 11-Octadecadienoic acid , methyl ester 
5 35.325 2.87 
11-Octadecenoic acid, methyl ester 
6-Octadecenoic acid, methyl ester 
9-Octadecenoic acid, methyl ester 
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Figure 3.12:  Gas Chromatography –Mass Spectrometry chromatogram of subfraction 5.1
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3.11 Nuclear magnetic resonance spectroscopy for subfraction 5.1  
Subfraction 5.1 was identified as 5,6,8-Trihydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-
chromen-4-one as shown in Figure 3.13 . 
 
      Figure 3.13: 5,6,8-Trihydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one 
Figure 3.14 shows the proton (
1
H) shift of the compound. Full proton characterization of 
subfraction 5.1 is outlined in Table 3.16. All the proton chemical shifts were observed in 
their respective and expected positions. 
 
        
        Figure 3.14: Proton chemical shifts for subfraction 5.1 
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Table 3.16: Subfraction 5.1 proton (H
1
) assignment  
 
Chemical shift Number of protons Coupling constant and multiplicity Assignment 
12.78 1 S OH 
10.72 1 S OH 
10.26 1 S OH 
7.99-7.92 2 M ArH 
6.98-6.92 2 M ArH 
6.55 1 S Alkene H-1 
3.79 3 S OMe 
3.76 3 S OMe 
 
The H
1
 NMR elucidation yielded chemical shift assignments: 
1
H NMR (DMSO-d6): δ ppm: 12.78 (s,1H, Ar-OH), 10.72 (s, 1H, Ar-OH), 10.26 (s, 1H, Ar-
OH), 7.99-9.92 (m, 2H, Ar-H), 6.98-6.92 (m, 2H, Ar-H), 6.55 (s, 1H, Alkene H-1), 3.79 (s, 
3H, OMe), 3.76 (s, 3H, OMe). 
Figure 3.15 shows the carbon (
13
C) shift of subfraction 5.1. Full carbon characterization is 
shown in Table 3.17.  
 
      
       Figure 3.15: Subfraction 5.1 carbon chemical shifts 
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Table 3.17: Subfraction 5.1 carbon (C
13
) assignment 
Chemical shift Assignment Chemical shift Assignment 
178.64 C=O 130.58 ArC 
160.63 ArCO 121.07 ArC 
157.76 ArCO 116.10 ArC 
156.14 ArCO 105.09 ArC 
152.87 ArCO 94.43 C-1 
152.02 ArCO 60.44 OMe 
137.75 ArC 60.14 OMe 
131.59 ArC   
 
The C
13
 chemical shifts were observed in their respective positions; 
C
13
 NMR (DMSO-d6): δ ppm: 178.64 (C=O), 160.63 (ArCO), 157.76 (ArCO), 156.14 
(ArCO), 152.87 (ArCO), 152.02 (ArCO), 137.75 (ArC), 131.59 (ArC), 130.58 (Ar), 121.07 
(ArC), 116.10 (ArH), 105.09 (ArC), 94.43 (C-1), 60.44 (OMe), 60.14 (OMe). 
 
3.12 Infrared analysis of subfraction 5.1 
The results from IR analysis of subfraction 5.1 are shown in Figure 3.16. Table 3.18 gives a 
summary of the observed infrared absorption bands for subfraction 5.1 
  
 
Figure 3.16: Infrared spectrum of subfraction 5.1 
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Table 3.18: Summary of the observed infrared absorption bands for subfraction 5.1  
Wavelength (cm
-1
) Vibration Reference 
3230-3550 O-H stretch 
Clark, 2000 
2880-2998 C-H stretch 
1744 C=O stretch 
1469-1651 C=C stretch 
1358 C-O 
1282-1358 C-O-C stretch 
1000-1168 C-C stretch 
806 C-OH 
 
 
3.13 Human embryonic kidney epithelial cells cytotoxicity study 
The cytotoxicity effect of D. viscosa var. angustifolia crude extract and purified subfraction 
were performed on the HEK293 cell line by the MTT assay method. Dose response graphs 
were constructed for both tests.  Figure 3.17 shows the crude extract microtitre plate assay 
after the addition of 100% DMSO. The absorbance values are presented in Table 3.19 
 
                          Figure 3.17: Crude extract cytotoxicity assay after the addition of MTT
Test samples (3 repeats) 
25mg/ml - 0.0125mg/ml  
 
Cell suspension only  
DMSO control 
Triton X (+ve control) 
Media only (blank) 
25mg/ml 0.0125mg/ml 
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         Table 3.19: Crude extracts cytotoxicity assay absorbance values  
T
es
t 
w
el
ls
 
M
ed
ia
 o
n
ly
 (
b
la
n
k
) 
T
ri
to
n
 X
 (
+
v
e 
co
n
tr
o
l)
 
D
M
S
O
 c
o
n
tr
o
l 
U
n
tr
ea
te
d
 c
el
ls
 (
-v
e 
co
n
tr
o
l)
 
2
5
 m
g
/m
l 
1
2
.5
 m
g
/m
l 
6
.2
5
 m
g
/m
l 
3
.1
2
 m
g
/m
l 
1
.5
6
 m
g
/m
l 
0
.7
8
 m
g
/m
l 
0
.3
9
 m
g
/m
l 
0
.1
9
 m
g
/m
l 
0
.0
9
 m
g
/m
l 
0
.0
5
 m
g
/m
l 
0
.0
2
 m
g
/m
l 
0
.0
1
 m
g
/m
l 
R
ep
ea
ts
 
0.073 0.091 0.486 0.567 0.074 0.098 0.111 0.132 0.143 0.163 0.187 0.25 0.279 0.316 0.389 0.447 
0.068 0.083 0.51 0.545 0.111 0.085 0.084 0.136 0.159 0.186 0.216 0.247 0.281 0.328 0.372 0.468 
0.078 0.086 0.528 0.427 0.078 0.092 0.128 0.13 0.161 0.178 0.198 0.233 0.294 0.319 0.396 0.438 
Avg 
0.073 
0.087 
 
0.508 0.513 0.088 0.092 0.108 0.132 0.154 0.176 0.2 0.243 0.285 0.321 0.386 0.451 
±SD 
0.004 0.003 0.017 0.061 0.017 0.005 0.018 0.002 0.008 0.01 0.012 0.007 0.006 0.005 0.01 0.012 
*I% 
- 97.1 1.14 - 96.6 95.7 92.1 86.6 81.59 76.59 71.14 61.36 51.88 43.64 28.86 14.1 
                                                                                                                                                                                                                                  * I%- Growth Inhibition (%) 
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The concentration of the crude extract ranged from 25 mg/ml to 0.0125 mg/ml. Results 
showed that the antiproliferative effect of D. viscosa var. angustifolia crude extract was dose 
dependent. The cytotoxic effect of the crude extract was calculated as the percentage cell 
growth inhibition using the following formula:  
                         
                               
                       
      
 
The level of susceptibility of HEK 293 cells to the crude extract was characterized through 
the use of IC50 values. This is the drug inhibitory concentration that reduces the absorbance 
of treated cells by 50% with respect to untreated cells. The IC50 was initially estimated using 
Figure 3.18 which shows the viability of cells treated with different concentrations of D. 
viscosa var. angustifolia methanol crude extract.  
 
       Figure 3.18: Viability of cells treated with D. viscosa var. angustifolia crude extract 
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The crude extract concentration that reduced the absorbance of treated cells by nearly 50% in 
relation to untreated cells (IC50) was estimated from the cell viability graph as 0.09 mg/ml, 
with a calculated value 51.88% cell growth inhibition. 
 
Preliminary cytotoxicity tests were done for subfraction 5.1 to determine which range of 
concentration values to use for treating HEK 293 cells. Significant cell death was observed at 
0.25 mg/ml of plant extract. Hence a concentration range of 0.25 mg/ml to 0.002 mg/ml was 
used to determine the IC50. Figure 3.19 shows the cytotoxicity assay of subfraction 5.1 on 
HEK 293 cells after the addition of 100% DMSO to dissolve the formazan crystals. Table 
3.20 gives an outline of the absorbance values recorded from subfraction 5.1 cytotoxicity 
assays at 570 nm. 
 
                      Figure 3.19: Subfraction 5.1 cytotoxicity assay after the addition of MTT  
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The cytotoxic effect of subfraction 5.1 was calculated as the percentage cell growth 
inhibition using the following formula:  
 
                         
                               
                       
      
 
 Table 3.20: Test absorbance values for subfraction 5.1 cytotoxicity assay.   
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0.071 0.086 0.792 0.802 0.094 0.102 0.299 0.439 0.512 0.716 0.557 0.687 
0.076 0.097 0.808 0.797 0.086 0.111 0.294 0.423 0.521 0.548 0.612 0.741 
0.077 0.084 0.798 0.81 0.075 0.111 0.302 0.418 0.498 0.561 0.755 0.784 
Avg 0.075 0.089 0.799 0.803 0.085 0.108 0.298 0.427 0.510 0.608 0.641 0.737 
±SD 0.002 0.006 0.007 0.005 0.008 0.004 0.003 0.009 0.009 0.076 0.083 0.039 
*I% - 98.04 0.5 - 98.58 95.42 69.29 48.35 40.18 26.73 22.20 9.02 
                                                                                                       * I%- Growth Inhibition (%) 
 
The level of susceptibility of HEK 293 cells to the subfraction was characterized through the 
use of IC50 values. The subfraction concentration that reduced the absorbance of treated cells 
by nearly 50% in relation to untreated cells (IC50) was estimated from the cell viability graph 
as 0.03 mg/ml (Figure 3.20), with a calculated value 48.35% cell growth inhibition. The 
antiproliferative effect was shown to be also dose dependent as shown in Table 3.20.   
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           Figure 3.20: Viability of cells treated with D. viscosa var. angustifolia subfraction 5.1 
 
The IC50 values of the methanol crude extract and subfraction 5.1 are presented in Table 3.21. 
Subfraction 5.1 was more cytotoxic to HEK 293 cells than the crude extract. For both assays, 
the cytotoxic effect was dose dependent.  
 
Table 3.21: The IC50 values of tested D. viscosa var. angustifolia crude extract and 
subfraction 5.1 
 
Plant extract HEK 293 (IC50) 
Methanol crude extract 0.09 mg/ml ±0.006 
Subfraction 5.1 0.03mg/ml± 0.008 
       SD: n = 3 
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                                           CHAPTER 4  
                                                            Discussion 
 
In 2007, the World Health Organization (WHO) declared that, tooth decay ranked as the 
most expensive infection that most people would have to cope with in their lifetime 
(Petersen, 2008). Dental treatments and subsequent sick leave cost billions of dollars 
annually (Samaranayake, 2002). The improvement of livelihood in third world countries as 
their populations become exposed to various sugary diets, has also correlated with the rise in 
dental caries worldwide. To avoid the burden of dental caries treatment costs and the amount 
of manpower involved, the slogan ‘prevention is better than treatment’ seems more plausible 
than ever before.  
 
The primary use of effective anticariogenic agents in conjunction with mechanical practices 
like teeth brushing could be vital in preventing dental caries. There have been various 
attempts to use antibiotics clinically in the prevention of dental caries. The downside to that 
have been adverse side effects like hypersensitivity reactions, teeth staining and the fact that 
most caries causing bacteria have some form of resistance to antibiotics largely due to the 
indiscriminate use of these antibiotics (Singh et al., 2007). Literature is full of reports 
concerning the use of natural products in preventing dental caries. As previously mentioned, 
most of these studies have focused on the use of crude extracts of plants. This quick approach 
is indeed essential for screening purposes. There is however, the need to better understand 
the chemistry of the plants to maximize their potential through the isolation of actual 
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anticariogenic constituents. The purification process also limits any antagonistic effects that 
may arise from the use of crude extracts.  
 
The potential use of D. viscosa var. angustifolia in preventing dental caries has been 
previously reported and the results were positive. Patel et al (2013) stated that its crude 
extract was able to reduce biofilm formation and acid production by the dental caries causing 
bacteria, S. mutans. The authors did highlight the need to identify the active constituents. 
This suggestion is echoed by most researchers in phytomedicine with the goal of maximizing 
the potential of medicinal plants. Therefore this study focused on the isolation of the active 
constituent from D. viscosa var. angustifolia with the potential to prevent caries causing 
pathogenic characteristics of S. mutans. This was followed by elucidation of the potential 
active compound and determining its cytotoxic effect on human embryonic kidney cells.  
 
In this study, six fractions were collected from fractionation of the methanol crude extract. 
These were labeled fraction 1-6 (F1-F6). Preliminary screening of the fractions showed that 
fraction 5 (F5) had the highest antimicrobial activity as indicated by its lowest minimum 
inhibitory concentration. The same outstanding effect from F5 was observed when 
subinhibitory concentrations of the fractions were tested for their effect on biofilm formation 
and acid production by S. mutans. Purification of F5 produced two subfractions, subfraction 
5.1 and subfraction 5.2. Further antimicrobial assay tests showed that subfraction 5.1 had 
more anticariogenic properties. Its efficacy had greatly improved compared to the crude 
extract. This study also reports the identification of this subfraction 5.1 compound which has 
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not been previously reported from D. viscosa var. angustifolia. Each step of this process will 
be discussed under relevant subheadings. 
 
4.1 Extraction and fractionation 
Taking into consideration the rapid growth of the herbal medicine industry in recent years, it 
has become necessary to establish integrated methods of extracting, purifying and 
characterizing bioactive compounds and ultimately ways to test their biological activity. 
Extraction is a very important initial step in analyzing medicinal plants. It facilitates further 
separation and eventual characterization of the bioactive chemical components. There is 
always a possibility that potential bioactive constituents are lost, distorted or even degraded 
during the extraction process. Fabricant and Farnsworth (2001) highlighted that, if the plants 
are chosen based on the way they are used traditionally,  it is important to prepare the extract 
in relatively the same way as traditional healers in order to mimic the ‘herbal drug’. 
 
A large proportion of antimicrobial compounds that have been identified from medicinal 
plants in literature are either aromatic or saturated organic compounds. For this reason, 
methanol was chosen as the initial solvent of extraction. Methanol has a polarity index of 5.1 
and is ideal for the extraction of both polar and a vast number of non-polar compounds. In 
addition, its low boiling point of 65°C made it easy to concentrate the bioactive compounds. 
An average yield of 6.8 grams dried extract from 60 grams (11.33%) of dried D. viscosa var. 
angustifolia leaves powder was attained.  
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Natural products consist of a vast number of constituents and in many cases; the bioactive 
constituents are present in minute amounts. Column chromatography facilitates the 
separation of these constituents by utilizing the fact that they migrate differently per given 
stationary phase and mobile phase used. Since the identity of the active constituents was 
unknown, gradient elution was used to enable the collection of fractions consisting of 
compounds that are possibly structurally related. Thin layer chromatography was used to 
analyze the composition of collected fractions and determine which solvent systems could 
effectively separate the individual constituents. 
 
4.2 Thin layer chromatography and Bioautography 
Thin layer chromatography is widely used during purification of plant constituents because 
of its low cost and ability to screen many samples at once. Thin layer chromatography was 
done in conjunction with a technique called contact bioautography. Contact bioautography is 
technique used to identify any TLC bands that have antimicrobial activity. The technique 
also aids in determining if any antimicrobial activity observed from the fractions is due to a 
single constituent or combinations of constituents.  Fraction 5 exhibited the biggest zone of 
inhibition (6 mm) at Rf 0.17 which indicated that the active constituent was a polar 
compound. The same zone of inhibition was observed when the crude extract was run on 
TLC though the zone of inhibition was smaller due to the lower quantity of the active 
constituent.  
 
Contact bioautography has its own limitations. It is more of a qualitative technique. The 
quantity of constituent that caused the zone of inhibition is not known. That raises the 
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possibility that there might be some more potent compounds that were present but did not 
cause any inhibition due to their low concentrations. However, the technique is useful for 
preliminary screening of antimicrobial activity in phytochemicals. The definitive 
antimicrobial properties were determined using MIC/MBC techniques.  
 
4.3 MIC/MBC assays 
 
All the six fractions from D. viscosa var. angustifolia had an antimicrobial effect on the two 
S. mutans test strains. One of the challenges experienced when carrying out MIC tests using 
crude extracts or fractions from plants is that plants have a variety of pigments. That becomes 
a problem when one is using dyes like INT or MTT to detect growth. For this particular 
study, fractions consisted of three colours, green, yellow and orange. The dye chosen, INT 
turns red when reduced by viable bacteria which facilitated easy detection of bacterial 
growth.  
 
The median MBC for the crude extract on both S. mutans strains was 1.56 mg/ml which was 
consistent with Naidoo (2012) who reported the same MBC results from D. viscosa var. 
angustifolia. Lee et al, (2007) reported a growth inhibitory concentration of 1 mg/ml against 
S. mutans from the crude extract of Saussurea lappa. More et al, (2008) reported MICs 
greater than 25 mg/ml when testing a series of South African plants used against oral 
pathogens including S. mutans. High values of MICs are usually observed with many crude 
extracts of plants when tested against S. mutans which suggest that these bacteria are difficult 
to kill compared to many pathogens. Sometimes the active constituents are present in small 
quantities in crude extracts. Another reason is that there could be antagonistic constituents 
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that promote growth of bacteria leading to high concentrations of crude extract needed to 
inhibit growth (Khurram et al, 2009). That raises the question though, what is the ideal MIC 
range of values that can establish a plant as a potential source of compounds that can be used 
in oral medicine? Unless the antimicrobial activity is due to synergy, fractionating the crude 
extract and isolating the active constituent does improve MIC values. 
 
Six fractions were collected from the crude extract. Their MICs ranged from 0.39 mg/ml to 
12.5 mg/ml. Fraction 5 and 6 had the lowest MICs with 0.39 mg/ml and 1.56 mg/ml 
respectively. Bioautography showed that the antimicrobial activity observed in fraction 6 
could have been same constituent in fraction 5 collected during fractionating. Among the 
fractions, only fraction 5 had a better MBC value compared to the crude extract. This 
indicated that the dilution effect with the other chemical present in the crude extract was 
removed by purifying the fraction. Screening plants for antimicrobial activity and isolating 
active constituents raises the issue of quantity. In some cases, the most active constituent is 
only present in very minute quantities compared to less active constituents. Therefore, Kotze 
and Eloff (2002) suggested the concept of total activity. Total activity is calculated by 
dividing the mass of the fraction or constituent by its MIC. A high mass and low MIC gives a 
high total activity value. Fraction 5 had the highest total activity value of 2000 with fraction 
4 having the lowest at 3.2. Nevertheless, all the fractions were then tested for their 
anticariogenic activity (biofilm formation and acid production).  
 
 
 
 
 
101 
 
4.4 Fractions and  biofilm formation 
 
The basis for the development of dental caries is the initial accumulation of endogenous acid 
producing bacteria on teeth surfaces. Micro colonies of bacteria live on teeth forming part of 
dental biofilms also known as dental plaque. A number of techniques have been performed to 
determine the potential of phytochemicals in reducing or eliminating oral biofilms. Most of 
these methods are focused more on preventing the cariogenic properties of S. mutans like 
biofilm formation than killing the bacteria. These anti-pathogenic phyto-compounds are 
preferred to those that kill bacteria. Bactericidal activity leads to selective pressure and 
subsequent resistance (Palombo, 2009). The same concept was applied for this particular 
study, only subinhibitory concentrations were used for the assays. The idea is to target S. 
mutans virulence rather than killing the bacteria. 
 
Depending on the individual MBCs, three subinhibitory concentrations per fraction were 
used for the biofilm assays. All the fractions had an inhibitory effect when compared to the 
controls. Fraction 5 had the highest biofilm inhibitory effect with 87.5% and 93.3% at 0.2 
mg/ml concentration after 6 and 24 hours respectively. This was followed by the crude 
extract which had 82.3% and 90.5% inhibitory effect at 6 and 24 hours respectively.  The 
high inhibition effect from fraction 5 is even more relevant by virtue of the fact that it had the 
highest biofilm inhibitory effect at the lowest concentration.  Similarly, Lee et al, (2007) 
reported that at 1 mg/ml, crude ethanol extracts from Saussurea lappa inhibited the 
adherence of S. mutans. It limited its ability to form the water insoluble glucan which is 
essential for biofilm development. Recent studies have shown that polyphenols found in 
cranberry juice inhibit glucosyltransferase thereby reducing insoluble glucan content 
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(Johnson-White et al, 2006). Dextran found in the flowering plant, Helichrysum italicum was 
shown to be essential in reducing cell aggregation and adherence of S. mutans to glass 
(Osaka et al, 2000). 
 
4.5 Fractions and acid production  
 
Acid production by S. mutans is essential for the onset of dental caries. Organic acids 
produced by plaque bacteria as by-products lead to dissolution of the teeth’s crystalline 
surface. Streptococcus mutans is part of acidogenic and aciduric bacteria. They thrive in 
acidic environments. Phytochemicals that are able to inhibit the glycolytic pathway in 
bacteria are of interest. The study therefore also investigated the effect of fractions on acid 
production by S. mutans. 
 
Streptococcus mutans cells were incubated in the presence of subinhibitory concentrations of 
D. viscosa var. angustifolia fractions. The pH was measured at 0 and 8 hours, then every 2 
hours up to 14 hours in total. All the fractions inhibited acid production by S. mutans. After 
10 hours of incubation, the control cultures attained the critical pH of 5.5 which promotes 
cariogenicity. When the pH levels drop below 5.5, the process of enamel demineralization 
ensues. Fraction 5 exhibited its high anticariogenic effect by having the least change in pH 
after 14 hours and the bacterial counts showed that the change in the pH was not count 
dependent. The assumption is that there was a constituent in the fraction that had a high 
inhibitory effect on the S. mutans glycolytic pathway. 
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Green tea has been shown to interfere with acid production by S. mutans. It exerts its 
anticariogenic effect by inhibiting the bacterial enzyme lactate dehydrogenase. That effect 
stops the production of lactic acid. The inhibitory agent was reported to be a catechin 
compound (Hamilton-Miller, 2001). Catechin is reported to be present in D. viscosa var. 
angustifolia (Naidoo et al, 2012). Hamilton-Miller (2001) does however, highlight that this 
antibacterial activity from tea can decrease because catechins have an affinity for proteins 
which leads to the loss of their activity.  
Fraction 5 certainly had the beneficial chemical constituent and therefore was purified 
further. 
 
4.6 Sub-fractionation of fraction 5 
Successful isolation of active constituents from plants is very much dependent on the solvent 
combination used. When screening and isolating active compounds from plants, it is 
important to preserve the integrity of the sample through the different purification stages. 
Liquid chromatography is done at room temperature, which makes it ideal for the isolation of 
compounds that may be thermally labile. However, liquid chromatography analysis is slow 
and in some instances, it does not provide optimum resolution of the band. The sample had to 
be re-run a couple of times to achieve complete resolution of the two subfraction peaks.  
 
The solvent gradient combination of hexane and ethyl acetate separated the crude extract into 
fractions effectively.  For further purification of fraction 5, the same solvent gradient 
combination was used starting with 100% hexane to 100% ethyl acetate. Sequential liquid 
chromatography fractionation in conjunction with thin layer chromatography and 
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bioautography lead to the isolation of two subfractions (5.1 and 5.2) that showed 
antimicrobial activity.  
 
4.7 MIC/MBC of subfraction 5.1 and 5.2  
Both the subfractions exhibited antimicrobial activity against S. mutans. Subfraction 5.1 
showed a pronounced inhibitory effect with an MIC of 0.1 mg/ml compared to the crude 
extract (0.78 mg/ml) and fraction 5 (0.39 mg/ml). In addition, subfraction 5.1 had high total 
activity. In some cases, potential activity can be lost when compounds are separated due to 
synergy. Bioassay guided purification steps like the utilization of bioautography make it 
possible to determine loss or gain of activity during the isolation process.  The subfractions 
were analyzed for any loss or gain in activity after liquid chromatography analysis. The 
results indicated that the active compound was now present at higher concentrations in 
subfraction 5.1 than for subfraction 5.2. This conclusion was drawn from the lower MIC 
value against S. mutans compared to the crude extract and fraction 5. Bioautography analysis 
of subfraction 5.1 also showed a bigger zone of inhibition compared to fraction 5. If synergy 
was a key factor in the antimicrobial activity of D. viscosa var. angustifolia, purification of 
the fractions showing antimicrobial potential might have led to loss of activity. 
 
Therefore subfraction 5.1 was further purified and identified. 
 
4.8 Identification and elucidation of subfraction 5.1    
Subfraction 5.1 was selected for GC-MS analysis based on its antimicrobial activity against 
S. mutans and purity. The main chemical compounds that were identified by GC-MS analysis 
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are outlined in Table 3.15.  Gas chromatography-mass spectrometry analysis is an important 
step towards the elucidation of an isolated compound. The molecular ion data from GC-MS 
analysis of subfraction 5.1 provided guidance as to the molecular weight and elemental 
composition of the compound. In essence, GC-MS fragments the molecule and this is termed 
electron ionization (EI). The detected EI fragment ions provide daughter ion peaks with 
corresponding mass to charge ratio (McShane, 2011). Hence the interpretation of the GC-Ms 
data involves working backwards and putting the ‘pieces’ back together to get a result.  
 
Interpretation of the GC-MS results from analysis of subfraction 5.1 gave an indication that 
the compound could be a flavonoid. Retention values of subfraction 5.1 using solvents 
reported in literature and the colour of the dried extract also pointed towards that conclusion. 
There are different types of flavonoids. The list includes flavones, flavonols and catechins. 
All these compounds have different absorbance spectrums. Subfraction 5.1 analysis using the 
ultra-violet visible spectrometer showed two peaks at 330nm (band A) and 270nm (band B). 
The results narrowed the possible identity of the compound to a group of flavonoids called 
flavones. Their absorption spectra fall within the range of 310 nm-350 nm for band A and 
250nm-290nm for band B (Tsimogiannis, 2007). 
 
Nuclear magnetic resonance spectroscopy was used for final characterization of subfraction 
5.1. The isolated compound was identified as a flavone.  Spectral data was attained for 
1
H 
NMR (Table 3.16 and Figure 3.13) and 
13
C NMR (Table 3.17 and Figure 3.14). Subfraction 
5.1 was identified as 5,6,8-Trihydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one 
with an empirical formula of C17H14O7. Further NMR spectral data was collected which 
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included NOESY, HMBC and HSQC correlations (See appendix).  Naidoo et al 2012 
reported the presence of 3-Hydroxy-5,7-dimethoxy-2-(4-methoxyphenyl)chroman-4-one 
from D. viscosa var. angustifolia. 
 
The crude extract of D. viscosa var. angustifolia is known to contain a lot of methylated 
flavonols and flavones (Omosa et al, 2010). The flavone from this study was eluted with a 
high concentration of ethyl acetate. The results are in correlation with the findings of 
Sachdev and Kulshreshtha (1982) who isolated two flavones, penduletin and 5,7,4’-
trihydroxy-3,6-dimethoxyflavone from the ethyl acetate fraction of D. viscosa. Ghilbert 
(1998) reported the presence of 23 flavones from flowers, seeds, leaves and bark of D. 
viscosa. Close to 50% of those flavones were methoxylated at C-6. The flavone isolated from 
this study is methoxylated at C-7 and C-4
1
. Getie et al, (2000) were able to isolate relatively 
large quantities of the flavones, kaempferol and isorhamnetin from D. viscosa crude leaf 
extract. Teffo et al (2009) reported the presence of four flavones from D. viscosa var. 
angustifolia. They tested the susceptibility of four pathogens to the isolated compounds and 
the MIC’s ranged from 23 to 250µg/ml. The isolated flavone from this study, 5,6,8-
Trihydroxy-7-4
1
-dimethoxyflavone has not been previously identified from D. viscosa var. 
angustifolia.  
 
This identified compound was subjected to biofilm and acid inhibition assays. 
Reproducibility of the results was also established. 
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4.9 Subfraction 5.1 (5,6,8-Trihydroxy-7-41-dimethoxyflavone) and biofilm formation 
 
The effect of D. viscosa var. angustifolia on S. mutans biofilm formation was investigated 
using three subinhibitory concentrations from the crude extract and subfraction 5.1. The 
highest subinhibitory concentration from subfraction 5.1 (0.05 mg/ml) exhibited a 
statistically significant biofilm inhibitory effect (p < 0.01). The purified subfraction showed a 
great improvement in anti-cariogenicity potential compared to the crude extract and fraction 
5 at lower concentrations. This indicated that the flavone was the active agent and the activity 
was not reliant on synergy.   
 
There are various reports that have discussed the effect of flavones on glucosyltransferase 
(GTF) enzymes found in S. mutans. Glucosyltransferase (GTF) enzymes are essential for 
development of biofilm. They catalyze the conversion of sucrose to α- linked glucans which 
are insoluble. Glucans facilitate the attachment accumulation of S. mutans onto the teeth 
surface leading to biofilm formation (Koo et al, 2002). Koo et al (2002) also investigated the 
effect of flavonols and flavones on GTF enzymes. They reported a 40 to 90% inhibition of 
GTF enzymes in solution and 15 to 60% of inhibition on GTF enzymes attached to the 
surface at a concentration of 0.135 mg/ml.  These results explain the findings of Naidoo et al. 
(2012) who showed that the crude extract of D. viscosa var. angustifolia can inhibit the 
biofilm formation rather than remove the fully formed biofilm.  
 
The isolated flavone apigenin was able to inhibit 90.5 to 95% of GTF activity at a low 
concentration of 0.135 mg/ml (Koo et al, 2002). The authors also reported that the flavone 
did not have much of an effect on surface adsorbed GTF enzymes compared to those in 
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solution. The inhibitory effect was concentration dependent. For this particular study, 0.05 
mg/ml of the isolated flavone, 5,6,8-Trihydroxy-7,4
1
-dimethoxyflavone reduced S. mutans 
biofilm formation by 94% and 98.9% after 6 and 24 hours of incubation respectively. The 
inhibitory effect was also concentration dependent.  
 
There are relatively few studies that have reported on the mechanisms by which flavonoids 
exert their antibacterial effect. The general consensus is that individual flavonoids with 
antimicrobial activity target various sites than one specific location of activity. Osawa et al 
(1992) examined the activity of various flavones on S. mutans and S. sobrinus. They 
observed that 5-hydroxyflavones and 5-hydroxyisoflavones with more hydroxyl groups on C-
7 and C-4
1
 did not have any inhibitory effect. However, Sato et al (1996) tested two 
isoflavones hydroxylated at 5, 2
1 
and 4
1 
positions using agar well diffusion assays. A strong 
inhibitory effect was observed against various streptococcal species. The assumption then is 
that C-2
1
 hydroxylation is vital for activity. The flavone from this study had high 
antimicrobial activity and is hydroxylated at 5,6 and 8. This highlights how the structure of 
the compound is important for activity.  
 
Other ways in which flavones exert their antimicrobial effect include the inhibition of DNA 
gyrase and rigidifying the membranes of bacteria. Fourteen flavonoids were screened for 
their effect on Escherichia coli DNA gyrase. DNA gyrase reduces the strain on DNA while it 
is being unwound. It was observed that seven of the selected compounds including the 
flavone apigenin inhibited DNA gyrase. However, there was no correlation between 
antimicrobial activity and enzyme inhibition which suggested that other mechanisms might 
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be involved (Ohemeng et al, 1993). Inhibition of cell membrane and cell wall synthesis are 
other modes of mechanisms that have been suggested for flavones (Zhang and Rock, 2004). 
Another biofilm inhibitory effect mechanism that has been reported is that flavonoids form 
complexes with cell surface proteins which lead to the reduction in overall cell 
hydrophobicity. Cell surface hydrophobicity is essential for biofilm formation (Prabu, 2005). 
 
 
4.10 Subfraction 5.1 (5,6,8-Trihydroxy-7-41-dimethoxyflavone) and acid production  
 
Streptococcus mutans has the ability metabolize dietary carbohydrates to produce acid which 
forms the basis of its virulence and pathogenesis of dental caries. The results showed that 
both the crude extract and subfraction 5.1 inhibited acid production by S. mutans. The same 
high inhibitory effect from subfraction 5.1 in comparison to the crude extract was observed. 
In addition, subfraction 5.1 inhibited acid production more effectively at low concentrations 
compared to crude extract. The inhibition effect was concentration depended. The bacterial 
counts which could have been the reason for the difference in pH between the controls and 
exposed assays were shown not to be very different. This indicated that there was a 
mechanism of activity being exerted by the crude extract and subfraction 5.1 that was not 
bactericidal in nature.  
 
 In addition to the fact that S. mutans is acidogenic, it is also acid tolerant with the ability to 
preserve its glycolytic capabilities at pH levels of up to 4.4 (Bender et al, 1985). 
Streptococcus mutans is able to survive in a low pH environment by increasing the activity of 
its F-ATPase enzyme which pumps protons out of the bacterial cell (Lemos and Burne, 
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2008). The activity of the F-ATPase enzyme makes the intracellular pH of the bacteria to be 
more than alkaline than the surrounding environment. This characteristic of S. mutans plays a 
crucial role in the development of dental caries (Banas, 2004). Guan et al (2011) therefore 
suggesting that to combat the caries causing ability of S. mutans, strategies that inhibit its 
acidogenic and acid tolerant properties would be the ideal solution. Any chemical that 
inhibits F-ATPase activity and the enzyme lactate dehydrogenase (LDH) which facilities the 
fermentation of dietary glucose to lactic acid would achieve that goal. 
 
Guan et al (2011) investigated the effect of two flavonoids, quercetin and kaempferol, 
isolated from the crude extract of Nidus vespae on the activity of LDH and F-ATPase found 
in S. mutans. They observed that when S. mutans cultures are exposed to 1/8-1/2 of the 
flavonoids concentrations, there was less than 10% antimicrobial activity on LDH. However, 
the same flavonoid concentrations were able to significantly inhibit F-ATPase activity. 
Quercetin reduced F-ATPase activity by 47.37% at half its S. mutans MIC. Kaempferol 
reduced F-ATPase activity by 49.66% also at half its S. mutans MIC. Some authors have 
suggested that the high inhibitory activity exhibited by flavonoids which include flavones is 
due to the fact that they are able to bind to bacterial extracellular proteins and form 
complexes. These complexes then bind to the bacterial cell wall (Cowan, 1999). By 
disrupting F-ATPase activity, the proton pumping ability of S. mutans is affected leading to 
an increase in acidity of the intracellular pH. That would affect the S. mutans pH sensitive 
glycolytic enzymes and subsequent loss of its acidogenic and aciduric properties (Guan et al, 
2011). Similarly, Prabu et al (2005) investigated the effect of the flavonoid guaijverin on acid 
production by S. mutans. At subinhibitory concentration, the flavonoid compound reduced 
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acid production by both S. mutans strains used. However, they postulated that the inhibitory 
effect may have been due to the bacteriostatic effect of the compound.  
 
Fluoride, a widely used anticariogenic chemical affects enzyme enolase which is responsible 
for the conversion of 2 phosphoglycerate to phosphoenolpyruvate which is responsible for 
the subsequent production of acid in the glycolytic pathways. The newly identified flavone 
may intercept this glycolytic pathway. 
 
The isolated flavone could have exerted its acid inhibitory effect through any of these 
mechanisms outlined. What is evident is that the structure of the compound plays a crucial 
role in the bioactivity. The positions of the hydroxyl groups and presence of methoxy groups 
do determine their antimicrobial and anticariogenic potential through structure-activity 
relationships. 
 
4.11 Cytotoxicity of crude extract and subfraction 5.1 (5,6,8-Trihydroxy-7-41-
dimethoxyflavone) 
   
The determination of cell viability is important in establishing the pharmaceutical toxicity of 
potential active ingredients for medicine (Komissarova et al, 2004). The effect of D. viscosa 
var. angustifolia crude extract and subfraction 5.1 on HEK 293 cells was investigated. The 
results were expressed as the concentration that inhibits 50% of cell growth in relation to 
untreated cells. According to IC50 values, HEK 293 cells were more susceptible to 
subfraction 5.1 than the crude extract after 24 hours of exposure. The results exhibited a dose 
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dependent cytotoxic effect for both assays. The methanol crude extract had an IC50 value of 
0.09 mg/ml and the purified subfraction had an IC50 value of 0.03 mg/ml. 
 
Beneficial effects of flavones have been reported in literature. Matsuo et al (2005) 
investigated the cytotoxicity effect of flavonoids including the flavone 4,5,7-
trihydroxyflavone (apigenin) on human lung embryonic fibroblasts (TIG-1) and human 
umbilical vein endothelial (HUVE) cells. The flavone apigenin had an IC50 value of 0.03 
mg/ml on both types of cells. The same IC50 result was reported in this study for the isolated 
flavone, 5,6,8-Trihydroxy-7,4
1
-dimethoxyflavone.   
 
Drug availability is a key factor for the success of any medicine. The washing action of 
saliva has to be considered when determining drug concentrations that will be effective in the 
oral cavity. The MIC of the isolated flavone from D. viscosa var. angustifolia on S. mutans 
was 0.1 mg/ml. All three subinhibitory concentrations from this compound (0.05, 0.025 and 
0.0125 mg/ml) showed inhibition of biofilm formation and acid production. The implication 
is that if the isolated flavone is used as the active component of any oral medicine at 
subinhibitory concentration, it would still exert its effect. When taking into consideration its 
IC50 value of the compound (0.03 mg/ml), the subinhibitory concentrations of the flavone 
active component would not be harmful for two reasons. The first reason is that, saliva would 
dilute the active ingredient to safe concentrations and that concentration would still be 
effective. The washing action of saliva also limits the exposure time of the chemical, which 
would also prevent any harmful activity on oral epithelial cells.  
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4.12 Clinical implications 
Cytotoxicity study has established the safe use of crude extract as well as the newly 
identified beneficial compound. Therefore both can be developed into an anticariogenic, oral 
hygiene product. These products can be toothpaste, mouthrinses and chewing gums. 
Identified chemical would be advantageous because the required concentrations would be 
lower. If the product is used at MIC/MBC concentrations it would reduce the number of S. 
mutans in the oral cavity. However, the constant flow of saliva would dilute this active 
ingredient gradually to subinhibitory concentrations represented in the acid and biofilm 
assays. At these concentrations the surviving S. mutans would not be able to form biofilm. In 
addition, they will not be able to produce acids. These two activities would reduce the 
process of development of dental caries. Recommendation of the usage of this compound in 
the form of toothpaste and mouth rinse would impart day and night protection. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
114 
 
Chapter 5 
Conclusion, Future research and limitations to the study 
 
5.1 Conclusion 
On fractionation of D. viscosa var. angustifolia crude extract, fraction 1, 2, 3, 4, 5 and 6 were 
identified and all the fractions showed varying levels of antimicrobial activity against S. 
mutans and inhibited biofilm formation and acid production. Among all the fractions, 
fraction 5 proved to have higher antimicrobial activity as well as high ability to reduce 
biofilm and acid production compared to the other fractions and crude extract. On 
subfractionation of  fraction 5, subfractions 5.1 and 5.2 were generated, of which subfraction 
5.1 proved to be the most active with an MIC of 0.1 mg/ml compared to the crude extract 
(0.78 mg/ml) and subfraction 5.2 (1.56 mg/ml). In addition at subinhibitory concentrations, 
subfraction 5.1 significantly inhibited biofilm formation and acid production at lower 
concentrations compared to the crude extract. These results suggested that subfraction 5.1 
contained an active anticariogenic compound which was originally detected in the crude 
extract.  Gas chromatography-mass spectrometry and NMR analysis identified that 
compound in subfraction 5.1 as the flavone, 5,6,8 Trihydroxy-7,4
l
-dimethoxyflavone.  
Cytotoxicity analysis of this flavone on HEK 293 cells revealed that the IC50 values are 
higher than the MIC and therefore it is safe to use in the oral cavity. The results in this study 
have shown that compound 5,6,8 Trihydroxy-7,4
l
-dimethoxyflavone present in the extracts of 
D. viscosa var. angustifolia is responsible for its potent anticariogenic activity and therefore 
it has potential to be developed as a anticariogenic therapeutic product.   
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5.2 Limitations of the study 
1. Dental plaque is composed of a variety of microorganisms and therefore ideally biofilm 
studies should be performed on mixed flora. However, it is difficult to study the effect on 
the virulence of any organism in a mixed flora environment. Therefore the S. mutans was 
used which is implicated in the development of dental caries and is the pioneer species in 
the development of plaque.  
2. The oral cavity has saliva which contains glycoproteins and antimicrobial compounds 
which may have effect on the biofilm. Saliva was not used in the study which would have 
been ideal to mimic the oral cavity environment due to the lack of availability of sterile 
clarified saliva. 
3. Streptococcus mutans produces extracellular polysaccharides which play a role in biofilm 
development. The effect of 5,6,8 Trihydroxy-7,4
l
-dimethoxyflavone on extracellular 
polysaccharide production was not done in the study due to the limited study time 
available to complete the degree. However, in future it will be pursued.  
4. Extract is lost during the purification process which might affect the yield attained. 
5. The pure form of the isolated compound was not available commercially for comparison 
of its antimicrobial and cytotoxicity effect.  
6. Other active compounds might not have been detected because they were present in 
minute amounts. 
7. Some constituents are volatile and light sensitive. It is possible that other potential active 
compounds might have degraded, losing their activity in the process.  
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5.3 Future research 
1. In vitro analysis does not provide a complete representation of what happens in the oral 
cavity. Clinical trials would be ideal in testing the isolated compound by incorporating it 
into a mouth rinse or toothpaste and determining its efficacy in preventing dental caries. 
2. Dental plaque is composed of a variety of organisms. Investigating the effect of the 
isolated compound on other microorganisms that are also found in dental plaque would 
be a step forward.  
3. Structure-activity relationships play a key role in the efficacy of compounds against 
microorganisms. Determining how the isolated compound exerts its effect against 
cariogenic bacteria at the biochemical level would be an important study. Plant 
compounds cannot be patented, hence if any analogues are to be developed; the 
biochemical mechanism by which the compound functions has to be known. 
4. The use of antimicrobial agents in conjunction with nanoparticles has gained popularity. 
The isolated compound can be coated onto nanoparticles to enhance its activity as well as 
retentiveness. 
5. Enzymes like glucosyltransferase, F-ATPase contribute to the pathogenicity of S. mutans.  
A study could be done to investigate the effect of the compound on such enzymes.  
6. The effect of the compound on the production of extracellular polysaccharides that 
contribute to development of dental plaque could be investigated. 
7. Phytochemical studies on D. viscosa var. angustifolia plants from different locations can 
be done as geographical variability can have an influence on chemical composition.  
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                                                        Appendices 
 
Appendix 1: Composition and preparation of media 
Blood agar 
39 g                     Columbia agar (Oxoid Ltd, UK) 
1000 ml               distilled water 
5 g                        sterile defibrinated blood  
 
39 g of Columbia agar base was suspended in 1000 ml distilled water. The suspension was 
boiled to dissolve completely. It was sterilized by autoclaving at 121 °C for 10 minutes. After 
cooling to below 50 °C, 5 % sterile defibrinated blood was added. The media was then 
poured into petri dishes and allowed to set. The plates were then refrigerated.  
 
Human cell culture medium 
88%                    Dulbeco’s modified eagle’s medium 
10%                    Fetal calf serum 
1%                      L-glutamine  
1%                      Streptomycin 
       
Dulbecos’s modified was supplemented with Fetal calf serum, L-glutamine and the antibiotic 
streptomycin according to the proportions mentioned above 
 
1X Phosphate buffered saline  
8 g                  sodium chloride 
0.24g              potassium hydrogen phosphate  
0.2g                potassium chloride 
1.44g              sodium hydrogen phosphate  
800 ml            distilled water 
 
The solids were suspended in 800 ml distilled water and autoclaved for 15 minutes 
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1X Trypsin-EDTA solution 
 
0.05 %                Typsin 
0.5 mM               EDTA 
1X                       PBS 
 
 
Tryptone Soya broth 
 
30 g                   Tryptone Soya broth 
500 ml               distilled water 
 
The media was dissolved in distilled water and autoclaved at 121 °C for 15 minutes 
 
 
5 % Sucrose Broth 
 
30 g                 Tryptone  
0.6 g                sucrose 
1000 ml           distilled water 
 
The solids were first boiled in 500 ml distilled water. The remaining water was then added, 
boiled and then autoclaved at 121 °C for 15 minutes.  
 
 
Semi-solid media 
 
1.125g            Columbia agar base 
100ml             Distilled water 
 
1.125g of Columbia agar base media was dissolved in 100 ml of distilled water, boilthen 
autoclaved at 121 °C for 15 minutes. 
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Appendix 2: NMR analysis of 5,6,8 Trihydroxy-7,4
1-
 dimethoxyflavone 
 
2.1:  COSY NMR (5,6,8 Trihydroxy-7,4
1
- dimethoxyflavone) 
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2.2: DEPT NMR (5,6,8 Trihydroxy-7,4
1
- dimethoxyflavone) 
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2.3: HMBC NMR (5,6,8 Trihydroxy-7,4
1
- dimethoxyflavone) 
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2.4: HSQC NMR (5,6,8 Trihydroxy-7,4
1
- dimethoxyflavone) 
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2.5: NOESY NMR (5,6,8 Trihydroxy-7,4
1
- dimethoxyflavone) 
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Appendix 3: Ethical clearance  
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Appendix 4: Statistics 
4.1: Statistics for effect of D. viscosa var. angustifolia crude extract and 5,6,8         
       Trihydroxy-7,4
1
-dimethoxyflavone on biofilm formation by S. mutans                  
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4.2: Statistics for effect of D. viscosa var. angustifolia crude extract and 5,6,8        
       Trihydroxy-7,4
1
- dimethoxyflavone on acid production by S. mutans 
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Appendix 5: Subfraction 5.1 (5,6,8 Trihydroxy-7,4
1
-methoxyflavone) mass spectra 
 
 
 
